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CHAPTER I
INTRODUCTION
1.1 Background
Atherosclerotic cardiovascular disease is the leading cause of death in the United
States. Cardiovascular disease (CVD) events such as a heart attack, stroke and peripheral
arterial disease are the culmination of a disease process that begins at a young age and
spans decades of a person’s life (Roger et al., 2012). Although CVD rarely manifests in
childhood, many risk factors and risk behaviors for the development and acceleration of
atherosclerosis begin in childhood (Daniels et al., 2011).
Predominant risk factors for CVD are family history, age, gender, hypertension,
dyslipidemia, overweight/obesity, diabetes, tobacco exposure, diet and physical
inactivity. There is increasing evidence that the number and/or severity of risk factors is
associated with CVD and that reducing risk factors delays disease progression (Berenson
et al., 1992; Magnussen et al., 2011). Thus, the aim of primary prevention for children
and adolescents is to identify and manage those at increased risk due to their identified
risk factors with the ultimate goal of risk reduction and thwarting CVD progression
(Raitakari et al., 2003; Webber, Srinivasan, Wattigney, & Berenson, 1991; Strong et al.,
1999).
Dyslipidemia is a term that describes abnormalities in lipoprotein metabolism and
often includes elevations in total cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C) or triglycerides or deficiencies in high-density lipoprotein cholesterol (HDL-C).
Disorders can be related to genetic conditions and/or multi-factorial with relationship to
1

2
risk factors as described above (US Preventive Services Task Force, 2007). Non-highdensity lipoprotein cholesterol (non-HDL-C) has recently emerged as a significant
predictor of atherosclerosis in both children and adults. Non-HDL-C appears to be more
predictive than TC, LDL-C or HDL-C for detecting dyslipidemia, atherosclerosis and
future CVD events (Frontini et al., 2008; Srinivasan, Frontini, Xu, & Berenson, 2006).
Non-HDL-C is especially advantageous in pediatric clinical practice because it can be
measured from non-fasting samples. Non-HDL-C is calculated by subtracting HDL-C
from TC which can be accurately obtained from non-fasting serum samples. Evidence
supports the use of non-HDL-C as a screening measure for dyslipidemia in youth and the
most recent screening guidelines include parameters for Non-HDL-C (Daniels et al.,
2011).
A series of observational studies exist which clearly demonstrate the correlation of
dyslipidemia with atherosclerotic development in youth (Daniels et al., 2011).
Postmortem studies on children, adolescents and young adults have found significant
associations between abnormal lipid levels and early atherosclerotic development of fatty
streaks and fibrous plaque (Berenson et al., 1992; Daniels et al., 2011). Childhood
dyslipidemia is also a predictor for increased carotid intima-media thickness, which is a
precursor for atherosclerosis (Raitakari et al., 2003).
Pediatric guidelines include targeted dyslipidemia screening for youth at risk
beginning at 2 years of age and universal screening between the ages of 17 and 21 years.
The primary risk factors used in this targeted approach are a family history of premature
CVD or dyslipidemia (Hagan, Shaw, & Duncan, 2008). In December 2011, the
American Academy of Pediatrics (AAP) endorsed the Expert Panel on Integrated
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Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents
(Expert Panel), which added to the existing recommendations, universal screening of all
children once between the ages of 9 and 11 years (Kavey, Simons-Morton, & de Jesus,
2011). This change was made in part, because recent research has shown that using
family history of premature CVD or dyslipidemia as the primary risk factor for pediatric
screening misses 30-60% of children with dyslipidemias (Derinoz et al., 2007). Other
predominant risk factors used to identify youth for targeted screening include
hypertension, diabetes, smoking and overweight. Of these risk factors, overweight
children and adolescents are especially of concern given the preponderance of obesity in
the US and the propensity of obesity itself to accelerate atherosclerosis (McGill et al.,
2001; Ogden, Carroll, Curtin, Lamb, & Flegal, 2010).
The American Academy of Pediatrics (AAP) follows the Centers for Disease
Control and Prevention (CDC) body mass index (BMI) overweight percentile cutoffs to
determine which youth meet the criteria for dyslipidemia screening. In children and
adolescents the preferred screening tool for weight status is the child’s BMI percentile
distribution relative to gender and age which is derived from CDC 2000 growth charts
(Kuczmarski et al., 2000; Daniels et al., 2011). Overweight children are defined as those
with BMIs at the 85th percentile or greater and obese youth are those with BMIs at the
95th percentile or greater. Overweight youth, those at the 85th percentile or greater are
considered at risk and dyslipidemia screening is advised (Barlow & the Expert
Committee, 2007).
Extensive research has shown a positive relationship between adiposity status and
CVD risk factors in youth. However studies on the relationship of dyslipidemia and BMI
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at the 85th percentile or greater are suggesting a need for additional research. Research
conducted on US children has predominantly examined the relationship of obese, not
overweight children and the development of atherosclerosis through pathology studies,
carotid artery imaging studies or lipid levels. International studies have found positive
associations between increasing levels of adiposity and more severe dyslipidemias.
However, this research is not readily generalized to the US population because
researchers used different classification systems for obesity and some studies were
conducted in Asian populations whose diets are dissimilar to American western foods
(Flechtner-Mors et al., 2011; Holl et al., 2011; Katzmarzyk, Tremblay, Perusse, Despres,
& Bouchard, 2003; Kim Soh Ye, Hong Kyung Hee, Jang Ki Hyo, Kang Soon Ah, &
Choue Ryo Won, 2005; Takada et al., 1998; Zhai et al., 2004). Additionally, in a recent
study Lee et al. (2009) found BMI did not provide effective discrimination for detecting
youth with elevated TC or LDL-C levels.
National expert organizations have designated BMI at the 85th percentile as the
screening threshold for youth at risk for dyslipidemia, however additional research to
support this cutpoint is needed. Although, the association of childhood obesity and CVD
is well documented, studies on US youth specific to the relationship of BMI percentiles
and dyslipidemia are lacking. There is a need to improve our understanding of
overweight youth and their risk for dyslipidemias.
1.2 Purpose of Study and Hypothesis
Although overweight children with BMIs at or greater than the 85th percentile
meet the at risk criteria for dyslipidemia screening, there is a scarcity of research on US
youth that specifically study this association. Analysis from Bogalusa researchers found
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CDC obesity BMI cutoffs to have low sensitivity and high specificity (Freedman, Mei,
Srinivasan, Berenson, & Dietz, 2007). This finding is important because sensitivity and
specificity respectively, refer to the ability of a test to correctly identify individuals with
or without disease. Additionally, a recent study on NHANES subjects using current
recommended screening thresholds found that BMI did not adequately identify youth
with abnormal TC and LDL-C levels and called into question the current screening
recommendations (Lee et al., 2009). Given the prevalence of overweight and obese
youth in the United States, screening recommendations based on a threshold of the 85th
BMI percentile results in a large number of children and adolescents to receive
dyslipidemia screening.
The purpose of this research is to add to the body of knowledge on childhood and
adolescent weight categories and their association with dyslipidemia. This research seeks
to elucidate whether US youth with BMIs at the 85th percentile or greater are at increased
risk for dyslipidemia compared to children and adolescents who are at a healthy weight.
The study group will consist of youth 6 to 18 years of age who participated in NHANES
during the cycle years from 2007 to 2010. The objective of using sample groups from the
latest NHANES surveys is to more closely mirror the current US population. The study
hypothesizes that children and adolescents who are overweight are at greater risk for
dyslipidemia compared to normal weight youth.

CHAPTER II
REVIEW OF THE LITERATURE
2.1 Cardiovascular Disease
Cardiovascular disease (CVD) is the leading cause of death and disability
worldwide. In 2008, 17.3 million deaths occurred worldwide due to CVD. Of these
deaths, 7.3 million were from heart attacks and 6.2 million from strokes (Mendis, Puska,
& Norrving, 2011). In the United States, for the past 90 years CVD has accounted for
more deaths than any other cause. Approximately one in three persons in the United
States has some form of CVD and one in three deaths are attributed to CVD.
Cardiovascular disease causes more deaths each year than cancer, accidents and chronic
lower respiratory diseases combined (Lloyd-Jones et al., 2009).
Cardiovascular disease includes diseases of the heart and vascular diseases of the
blood vessels to the heart, brain and peripheral arteries. In the adult, acute CVD events,
such as myocardial infarction and stroke, occur after the long-term development of
atherosclerosis and thrombotic events associated with atherosclerotic plaque instability.
In pediatrics, the primary component of this process is the development of
atherosclerosis, because CVD thrombosis does not occur in the absence of
atherosclerosis. Although CVD in children and adolescents is rare, risk factors and
behaviors that contribute to atherosclerosis often begin in childhood and there is
increasing evidence that reducing these risk factors can delay progression of
atherosclerosis and eventual CVD (Daniels et al., 2011).
6
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2.2 Expert Guidelines and Recommendations
To address this health issue, in 2006, an Expert Panel was appointed by the
National Heart, Lung, and Blood Institute (NHLBI) to conduct a formal evidence review
and to develop cardiovascular health and risk reduction guidelines for pediatric care
providers. The Expert Panel’s approach to this guideline development was characterized
by formal evidence review and integration of multiple major CVD risk factors into one
document. The Full Report of the Expert Panel is available on the NHLBI website and
these Expert Panel guidelines were endorsed by the American Academy of Pediatrics
(AAP) in 2011 (Daniels et al., 2011).
Prior to release of the Expert Panel’s report, guidance for dyslipidemia screening
in children was primarily presented through two publications, the AAP policy statement
Lipid Screening and Cardiovascular Health in Childhood and Bright Futures 3rd Edition
Guidelines. The AAP policy statement, published in 2008, presented three different sets
of guidelines to use in determining normal and abnormal lipid levels. One set of
guidelines was adapted from the 1992 National Cholesterol Education Program: Report
of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Another
was adopted from the American Heart Association, while a third, percentile ranking
table, was adapted from the Lipid Research Clinic Pediatric Prevalence Study. Although
the National Cholesterol Education Program (NCEP) and AAP recommend a targeted
approach to screen children with certain risk factors (i.e., family history of premature
CVD or hypercholesterolemia, diabetes, hypertension and obesity) research to optimize
screening protocols has not led to consensus in pediatric screening (Daniels, Greer, & the
Committee on Nutrition, 2008).
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In 2007, the US Preventive Services Task Force (USPSTF) (2007) concluded that
evidence was insufficient to recommend for or against routine screening for dyslipidemia
in youth and young adults up to age 20. The USPSTF could not address key questions
about screening and treatment of dyslipidemia in children and adolescents because
studies were lacking. However, due to the nature of pediatric research, pediatric
prevention unfortunately is often based upon less rigorous scientific evidence, and
“Insufficient” recommendations from the USPSTF are not uncommon (Daniels, Greer, &
Stettler, 2008; Moyer & Nelson, 2008). The lack of studies in this area of pediatric
research is due in part because longitudinal studies linking childhood risk factors to CVD
would involve extensive periods of time in the range of 50 to 60 years duration and
clinical trials of voluntary risk exposure in children are unethical (Daniels et al., 2011).
The recent report of the Expert Panel on Integrated Guidelines for Cardiovascular
Health and Risk Reduction in Children and Adolescents is a comprehensive review and
critical appraisal of every relevant study available on the multiple risk factors for CVD
development, progression and management. The Expert Panel followed an Evidence
Grading System adapted from the American Academy of Pediatrics Steering Committee
on Quality Improvement and Management. The Expert Panel assigned the Evidence
Review for Lipid Assessment in Childhood and Adolescence a Grade B (strongly
recommended). Evidence for a Grade B was based on randomized controlled trials or
diagnostic studies with minor limitations, genetic natural history studies, and/or
overwhelmingly consistent evidence from observational studies. The definition for a
strong recommendation as included in the report is that the benefits clearly exceed the
harms and that the quality of the supporting evidence is excellent. In some
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circumstances, strong recommendations were made on the basis of lesser evidence when
high-quality evidence was impossible to obtain and the anticipated benefits clearly
outweighed the harms. Unlike earlier policy statements and guidelines, the Expert Panel
Report has integrated the evidence and produced conclusive detailed tables and
algorithms to follow for lipid assessment that address age variance. The Expert Panel
determined that CV risk reduction in children and adolescents addresses the disease
process atherosclerosis, in which the clinical endpoint of manifest CVD occurs much
later in life (Daniels et al., 2011).
2.3 Atherosclerosis
Atherosclerosis is responsible for a large proportion of cardiovascular diseases. It
is an underlying pathological process in the blood vessels that develops over many years.
In atherosclerosis, plaque which consists of fatty substances and cholesterol, builds up in
arteries. Over time the plaque hardens and the arterial lumen narrows with resultant
decreased blood flow and potential clot formation. The atherosclerotic process often
leads to disruption of blood supply to vital organs such as the heart and brain, resulting in
cardiac and cerebral events (Mendis, Puska, & Norrving, 2011).
The earliest sign of atherosclerosis is the fatty streak, which is an accumulation of
lipid-filled macrophages in the intimal layer of the artery. Progression of atherosclerosis
occurs with accumulation of smooth muscle cells and fibrous tissue produced by the fat
laden smooth muscle cells. Over time the fatty streak evolves into a fibrous plaque, the
hallmark of established atherosclerosis. The buildup of plaque restricts blood flow by
narrowing arteries, hardening arterial walls and clot formation. Cessation of blood
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supply causes lack of oxygen and tissue infarction, which damages the affected tissues or
organs (Crowther, 2005; Daniels, Greer, & the Committee on Nutrition, 2008).
2.4 Childhood Risk Factors for Adult CVD
Most of the clinical burden of atherosclerosis occurs in middle to older adulthood,
but the pathological process of atherosclerosis begins in childhood (Juonala et al., 2010).
Pathology studies have confirmed the atherosclerotic process begins at a young age.
Autopsy studies of young soldiers killed in the Korean and Vietnam Wars found evidence
of atherosclerosis (Enos, Homes, & Beyer, 1953; McNamara, Molot, Stremple, &
Cutting, 1971). In the Korean War study, 300 soldiers who were battle casualties were
examined for gross lesions in the coronary arteries. The ages of the first 98 soldiers were
not recorded, except that the oldest was 33 years of age. The average recorded age of the
remaining 200 soldiers was 22 years of age, ranging from 18 to 48 years. Cases with
known clinical evidence of coronary disease were excluded from the study. Findings
indicated 77% had evidence of atherosclerosis (Enos, Homes, & Beyer, 1953; Le, Zhang,
Menees, Chen, & Raghuveer, 2009). In the Vietnam War study, postmortem
examination of 105 soldiers with coronary angiography and heart dissection revealed
45% with some evidence of atherosclerosis and 5% with gross evidence of severe
coronary atherosclerosis (McNamara et al., 1971).
The study, Pathobiological Determinants of Atherosclerosis in Youth (PDAY) was
a multi-institutional study which was initiated to document the natural history of
atherosclerosis, its relationship to risk factors, and the pathobiology of lesion
development in young subjects (Strong for the Pathobiological Determinants of
Atherosclerosis in Youth (PDAY) Research Group, 1995). PDAY studies conducted
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from 1987 to 1994, examined subjects from 15 to 34 years of age, because this is the age
when fatty streaks are prevalent and fibrous plaques begin to appear (Strong et al., 1999).
This study included 1079 males and 364 females, black and white, who died from
external causes (suicide, homicide and accidents).
PDAY studies have described the effects of age, sex, race, dyslipidemias,
smoking, hypertension, diabetes and obesity on the microscopic development of
atherosclerosis in youth and young adults. The extent of arterial intima involved with
fatty streaks and raised lesions increased with age in both sexes and race groups.
Investigators found strong relationships between the degree of atherosclerosis and the
extent of known risk factors, including increasing age, increasing levels of non-HDL-C,
lower HDL-C, hypertension, impaired glucose tolerance, smoking, and obesity in males.
The severity of atherosclerosis was markedly increased in subjects with multiple risks
(McGill et al., 2001; Strong for the Pathobiological Determinants of Atherosclerosis in
Youth (PDAY) Research Group, 1995).
PDAY researchers devised youth risk scores for predicting advanced
atherosclerotic lesions using modifiable risk factors of dyslipidemia, tobacco use,
hypertension, obesity and hyperglycemia. Subjects with higher risk scores had
significantly higher odds ratios for atherosclerotic lesions. The prevalence of advanced
atherosclerosis in the high-risk 15 to 19 year olds was nearly the same as low-risk 30 to
34 year old subjects (McMahan et al., 2006).
The Bogalusa Heart Study was a long-term epidemiologic study of cardiovascular
disease risk factors in persons from birth through 38 years of age. The study began in
1973 in the biracial community of Bogalusa, Louisiana. Bogalusa investigators

12
performed autopsy studies on 204 persons, 2 through 39 years of age. The causes of
death varied, but principally were due to accidents and homicide. Subjects were
evaluated for extent of atherosclerotic lesions in the aorta and coronary arteries.
Investigators found the extent of fatty streaks and fibrous plaque increased with age.
This age related trend was especially significant in the coronary arteries where the
prevalence of fibrous plaques increased from 8% in the 2 to 15 year old group, to 69% in
the 26 to 39 year old group (Berenson et al., 1998).
In the Bogalusa study, investigators conducted six cross-sectional surveys which
included over 3,500 children. The first survey examined 5 to 14 year old subjects.
Subsequent surveys were conducted throughout school age and beyond high school.
Findings from Bogalusa report on the positive association of cardiovascular risk factors,
body mass index (BMI), blood pressure, lipid levels and the development of
atherosclerosis in the aorta and coronary arteries (Berenson et al., 1998; Berenson et al.,
1992; Newman et al., 1986).
Two large studies utilized ultrasonography, a non-invasive method, to detect
atherosclerosis by measurement of carotid artery intima-media thickness (IMT), a
surrogate measure for CVD. The validity of using carotid IMT as a reliable marker for
atherosclerosis is well documented (de Groot et al., 2004; Roger et al., 2012). The
Rotterdam Study and the Atherosclerosis Risk in Communities (ARIC) Study found that
carotid IMT correlates positively and significantly with vascular risk factors and
cardiovascular disease. Additionally, in the ARIC study, carotid ultrasonography was
able to determine all stages of atherosclerosis (Bots, Hoes, Koudstaal, Hofman, &
Grobbee, 1997; Heiss et al., 1991.
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The Muscatine study was a longitudinal cohort study which began in 1971 with
biennial examinations of school children 8 to 18 years of age in Muscatine, Iowa.
Ultrasonography was used in the Muscatine study in the 1990s to determine the
relationship of higher carotid IMT with cardiovascular risk factors that occurred in
childhood and beyond. The study included 725 male and female participants who had
previously participated in at least one childhood survey and had reached the age of 33 to
42 years. In this cohort, childhood risk factors measured as early as 8 to 11 years of age
and predictive of high adult carotid IMT were TC for both men and women and BMI for
women (Davis, Dawson, Riley, & Lauer, 2001).
In the Bogalusa study, investigators measured carotid IMT to evaluate the
influence of gender, ethnicity and risk factors on early stages of atherosclerosis. The
study included 518 male and female subjects, with a mean age of 32 years. The subjects
were overweight, but otherwise healthy, asymptomatic young adults. Cardiovascular risk
factors evaluated included obesity, hypertension, dyslipidemia, hyperinsulinemia and
smoking. After adjustments for age, race and sex, carotid IMT was associated
significantly and positively with waist circumference, systolic blood pressure, diastolic
blood pressure, and LDL cholesterol. Carotid IMT was inversely correlated with highdensity lipoprotein (HDL) cholesterol levels. Participants with greater numbers of
adverse risk factors had stepwise increases in mean carotid IMT levels (Urbina et al.,
2002).
Probably the most compelling evidence that childhood dyslipidemia risk factors
are related to adult CVD is the manifestation of cardiovascular conditions. Familial
hypercholesterolemia (FH) is an autosomal dominant disorder characterized by
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abnormally high concentrations of LDL-C. FH is one of the most common inherited
disorders with an estimated worldwide prevalence of 1 in 500 (Austin, Hutter, Zimmern,
& Humphries, 2004). The dyslipidemia associated with FH leads to increased risk for
CVD and death. Risk for coronary heart disease (CHD) and cardiac events is much
higher with 50% of FH men and 25% of FH women experiencing clinical coronary
events by 50 years of age (Neil et al., 2008; Stone, Levy, Fredrickson, & Verter, 1974).
Adding to the evidence of causation, the use of statin medications to reduce dyslipidemia
in FH subjects has been shown to reduce morbidity and mortality (Neil et al., 2008).
Furthermore, the ARIC study found that persons with genetic traits associated with low
cholesterol had conferred protection against CHD and significantly lower measures of
carotid IMT (Cohen, Boerwinkle, & Hobbs, 2006). Collectively these studies helped to
establish the association of childhood dyslipidemia as a risk factor for adult CVD.
2.5 Childhood Risk Factors Track into Adulthood
Risk factors for CVD and atherosclerosis can be categorized as life conditions
(e.g., family history, age, gender), pathophysiologic (e.g., hypertension, dyslipidemia,
overweight, diabetes), behavioral (e.g., tobacco exposure, nutrition, physical activity) and
emerging (e.g., metabolic syndrome, inflammatory markers, perinatal factors) (Daniels et
al., 2011). The strongest risk factors include obesity, dyslipidemia, hypertension,
diabetes, and tobacco use (Daniels, Greer, & The Committee On Nutrition, 2008; Wilson
et al., 1998). Research has demonstrated that these pathophysiologic risk factors can be
present at young ages and track into adulthood (Berenson et al., 1998; Juonala et al.,
2005). A detailed review of all risk factors is beyond the scope of this thesis. Obesity
and dyslipidemia, individually, are broad topics. Because obesity and dyslipidemia as
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screening indices in childhood are the focus of this study, this literature review will aim
to present research findings relevant to childhood overweight/obesity and its’ associations
with dyslipidemia, although brief mention of other risk factors and related components of
overweight/obesity and dyslipidemia may be included.
In epidemiologic studies, tracking describes consistency and longitudinal
development of risk factors over time (Magnussen et al., 2011; Twisk, Kemper, &
Mellenbergh, 1994). From a pediatric viewpoint, tracking analyses are beneficial
because they can predict future values from early life measurements and aid in
determining which risk factors to target for primary prevention or treatment. Tracking
indicators are generally correlations between repeated measurements of an attribute at
different times and the proportion of participants that remain in the group. Due to
established associations of dyslipidemia and CVD in adults, blood lipid levels have been
studied for tracking in children and adolescents.
A number of prospective studies on the tracking of lipids from youth into
adulthood exist. In the Bogalusa Heart Study, a study cohort was derived and monitored
for an average of 27 years. There were 1163 subjects, 30% black and 55% female who
were 5 to 14 years at baseline. Investigators studied persistence of ranking of non-HDLC and LDL-C levels in quintile levels from childhood to adulthood. For both cholesterol
levels 66% of subjects who were above the 60th percentile in childhood remained above
the 60th percentile as an adult. Of the variables studied, baseline levels of non-HDL-C
and LDL-C were the best predictors for adult levels with standardized regression
coefficients of 0.36 and 0.40 respectively. Change in BMI from childhood to adulthood
was the next best predictor for both variables with standardized regression coefficients of
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0.20 for non-HDL-C and 0.22 for LDL-C. Children in age-, gender- and race-specific top
quartiles of non-HDL-C and LDL-C were compared to those in the bottom quartiles and
had odds ratios of 4.5 and 3.5 respectively to develop dyslipidemia (Srinivasan, Frontini,
Xu, & Berenson, 2006).
Muscatine investigators found that increased cholesterol values during childhood
were associated with increased values as adults. A cohort of 2446 subjects were initially
examined at 8 to 18 years of age, then re-examined between 20 to 30 years of age.
Eighty one percent of children who had cholesterol values above the 50th percentile
remained above the 50th percentile as an adult. Of those that were at or above the 75th
percentile, 62% remained at this level as an adult. For the highest level at or above the
90th percentile, 43% remained as adults. Fifty to 87% of children whose cholesterol
levels exceeded the 90th percentile were above the 75th percentile as adults. Conversely,
if children’s cholesterol levels were less than the 90th percentile, 78 – 84% were below
the 75th percentile as adults. The 75th percentile cutoff was used in this study because it
was the National Cholesterol Education Program recommended benchmark to implement
dietary interventions in adults with dyslipidemias (Lauer, Lee, & Clarke, 1989).
In the Cardiovascular Risk in Young Finns Study tracking and predictiveness of
lipid measurements of Finnish youth were analyzed over a 12 year period. The cohort
included 883 subjects from 3 to 18 years of age with 47% male. Spearman’s correlation
coefficients for 12–year tracking were as follows: TC 0.48-0.58, LDL-C 0.53-0.58,
HDL-C 0.53-0.58, LDL:HDL cholesterol ratio 0.57-0.59 and triglycerides 0.33-0.37.
Approximately 50% of participants who were in the extreme quintiles for TC, LDL-C
and HDL-C on initial exam remained in the same quintiles after 12 years. In multiple
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regression analyses, conducted by Porkka, Viikari, Taimela, Dahl, and Akerblom (1994)
childhood obesity, exercise, diet, and smoking habits did not markedly aid the prediction
of adult serum lipid values.
Friedman (2006) found a wide range of test agreement values in tracking of lipid
abnormalities from childhood to adulthood. The Princeton Lipid Research Clinics
Prevalence Program Follow-Up Study was a prospective study to determine sensitivity
and specificity of National Cholesterol Education Program (NCEP) pediatric cutoff
points during youth for adult lipid status. The derived cohort included children 5 to 19
years of age when initially studied in the Cincinnati Clinic of the Lipid Research Clinics
(LRC) Prevalence Study from 1972-1978. Study participants for the Princeton FollowUp Study (PFS) were students in 1st to 12th grade in public and parochial schools in the
Princeton School District. The study group was 73% white, 27% black, 52% male and
48% female. A total of 844 subjects were evaluated for LDL-C tracking and 897 subjects
for TC tracking. Guidelines from the NCEP were followed for determining adult
elevated TC and LDL-C levels (Friedman, 2006).
Reported overall sensitivities were 43 to 46% and specificities were 82 to 86% for
total and low-density lipoprotein cholesterol levels respectively. The positive predictive
values were 39% for TC and 31% for LDL-C. Negative predictive values were 88% for
TC and 91% for LDL-C. Researchers examined sensitivity and specificity of the entire
cohort according to age. Sensitivities ranged from 18% (16 years old) to 63% (11 years
old) for TC, and 22% (15 years old) to 69% (9 years old) for LDL-C. The highest
sensitivities occurred in the younger age groups between 5 and 11 years of age and the
lowest occurred at 14 to 16 years of age. Sensitivities seemed to be increasing in the 17
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to 19 year old groups (~49% TC and ~65% LDL-C) to levels similar to the younger ages.
The specificities were high ranging from 77 to 96%. This study was especially of merit
in delineating the variability in sensitivities at different ages.
Childhood to adult lipid tracking was described in another prospective study by
Stuhldreher et al., (1991). In the Beaver County Lipid Study investigators conducted
follow-up screening on 295 adults who had initially participated as children in a schoolbased screening program at the ages of 11 to 14 years. The follow-up phase of the study
was conducted 16 years after the baseline study conducted in 1972 -1973 when the
subjects had reached a mean age of 28 years. Overall correlation coefficients between
the baseline and follow-up study for TC levels were 0.44 (P<0.0001). Correlation
coefficients for women were higher (r = 0.51) compared to men (r = 0.38). Based on
recommended guidelines, cutoffs for elevated TC levels or positive test results were
established at 175 mg/dl in children and 200 mg/dl in adults. Researchers reported
sensitivity of 63%, specificity of 67% and a positive predictive value of 47% for
screening at 12 years of age and predicting elevated adult TC levels.
For this Beaver study, a false-positive test was a child who was above the cutoff as
a child, but not as an adult. A false-negative test was a child who was below the cutoff as
a child, but not as an adult. A comparison of test results found that male and female
subjects with false-positive results smoked significantly less than those with falsenegative results. In addition, false-positive males had a greater improvement between
evaluation periods in cholesterol-lowering dietary practices. Comparisons also revealed
that female subjects with false-positive results were less overweight and had a lower
prevalence of oral contraceptive use. Researchers surmised that although some subjects
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were misclassified as a result of childhood screening, some misclassification was
associated with adopting changes that would be promoted through a screening and
intervention program such as tobacco cessation, achieving healthy weight and dietary
changes.
2.6 Childhood Obesity Tracks into Adulthood
Of all the aforementioned pathophysiologic risk factors, obesity tracks from
childhood to adulthood the strongest (Daniels et al., 2011). Childhood levels of obesity
are epidemic in the US and since 1980 obesity prevalence in school aged children has
tripled. Data from the 2007 National Survey of Children’s Health and the 2007-2008
NHANES find approximately 32% of youth are overweight and approximately 17% are
obese (Odgen, Carroll, Curtin, Lamb, & Flegal, 2010 ; Singh, Kogan, & van Dyck,
2010). Reports from the most recent NHANES survey 2009-2010 indicate no change in
childhood obesity prevalence from 2007-2008 (Ogden et al., 2010).
Centers for Disease Control and Prevention (CDC) growth charts with BMI
percentiles relative to age and gender are the preferred reference to identify overweight
and obesity in youth from 2 to 18 years of age. Expert committee recommendations with
representation from 15 national health care organizations, recommend using BMI on
individual children in order to assess weight-for-height relationships. BMI as an obesity
measure has limitations such as, it does not directly measure body fat, and does not take
into account skeletal size or muscle mass (Wilk, 2007). Thus, a very muscular person
may have a BMI which falls into an overweight category. Although there are some
limitations, BMI is easily calculated, correlates strongly with direct measure of body fat
and has acceptable accuracy especially in identifying individuals with higher amounts of
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body fat, e.g. those above the 85th percentile. The expert committee convened by the
American Medical Association, the CDC and the Maternal and Child Health Bureau
(MCHB) has defined childhood and adolescent obesity as a BMI at or greater than the
95th percentile and BMIs between the 85th and 94th percentiles as overweight (Barlow &
the Expert Committee, 2007; Daniels et al., 2011).
Investigators from the Bogalusa Heart Study reported that childhood BMI is
associated with adult obesity. In this study with over 2600 participants, 77% of obese
youth (BMI at or greater than the 95th percentile) remained obese (BMI at or greater than
30 kg/m²) as an adult. Children 2 to 17 years of age were re-examined at 18 to 37 years
of age. The mean follow-up time was 17 years. The magnitude of correlations between
childhood and adult obesity increased with age of childhood measurement. The BMIs of
2 to 5 year olds were moderately associated with Spearman’s correlation coefficients at
0.50 and 0.45 for males and females respectively. Associations increased with age with
the strongest BMI association occurring in 15 to 17 year old adolescents 0.74 and 0.66
for males and females respectively (Freedman, Khan, Dietz, Srinivasan, & Berenson,
2001; Freedman et al., 2005).
Muscatine researchers report even higher tracking correlations for BMI that range
from 0.58 to 0.91. This study involved 2631 children from 9 to 18 years of age that were
followed into their young adult life and re-examined between the ages of 23 and 33 years.
An interesting finding in this study was that approximately 31% of children in the top
quintile of BMI became adults that fell into a much lower weight category and that
approximately the same percentage of lean children became obese adults. Similar to the
Bogalusa study, Muscatine investigators also found tracking associations increased as
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childhood age increased with correlations of adult Quetelet Index (weight divided by
height²) lowest at 0.45 in the 7 to 8 year old female group and reaching a maximum of
0.74 in the 13 to 14 year old males (Clarke & Lauer, 1993).
In the National Heart, Lung and Blood Institute Growth and Health Study (NGHS)
a cohort of 2379 bi-racial females were examined annually from the age of 9 or 10
through 18 to 19 years of age. NGHS-Wave II was conducted as a follow-up telephone
interview when the subjects were between 21 to 23 years of age. There were 2054
participants in NGHS-Wave II which included 991 Caucasians and 1063 AfricanAmerican girls. Overweight in youth up to 18 years of age was defined by attainment of
the 95th percentile for BMI, and for young adults 21 years of age and older BMI was
defined as at or greater than 30 kg/m². Study participants who were overweight from age
9 to 18 years were 11 to 30 times more likely to be obese as adults compared to not
overweight girls. Investigators noted the limitation that self-reported body measurements
in the follow-up study presented, but nonetheless found these strong associations
noteworthy (Thompson et al., 2007).
2.7 BMI as a Predictor for Dyslipidemias
Bogalusa researchers found that dyslipidemia was associated with increased BMI.
In the Bogalusa study, overweight children 5 to 17 years of age compared to normal
weight children were 2.4 times as likely to have elevated levels of TC, 3.0 times more
likely to have high LDL-C and 3.4 times as likely to have low HDL-C (Freedman, Dietz,
Srinivasan, & Berenson, 1999). NGHS researchers found strong associations between
obesity and some dyslipidemia markers. Obese females 9 to 18 years of age were 6.3
times more likely to have HDL-C levels less than 50 mg/dl, and 3.3 times more likely to
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have triglyceride levels at or greater than 130 mg/dl. Obesity in this cohort was not
significantly associated with elevated TC or elevated LDL-C levels. Researchers
adjusted for pubertal maturation as there was some association with lipids. In this
secondary analysis with adjustment for pubertal maturation, elevated LDL-C levels were
significantly associated with obesity with OR = 3.0 (P = .01). Total cholesterol remained
not significantly associated (Thompson et al., 2007).
Holl et al. (2011) report on their findings from a large cross-sectional study
conducted in Germany on subjects that were analyzed beginning in 2003. The study
purpose was to report on the effects of age, gender and obesity category on dyslipidemia
components. Participants included 29,711 overweight and obese subjects from the
German, Austrian and Swiss APV registry (mean age 12.61 + 3.14) and the comparison
group of 11,110 normal-weight subjects from the German Health Interview and
Examination Survey for Children and Adolescents, KIGGS (mean age 9.8 + 4.7).
Cutoffs for abnormal lipid values were based on American Heart Association
recommendations, and with conversion from mmol/L to mg/dl were approximately TC
greater than 200 mg/dl, HDL-C less than 35 mg/dl, LDL-C greater than 130 mg/dl, and
triglycerides greater than 150 mg/dl. Weight classifications used were different than the
customary US standard, and were based on BMI-SDS values calculated with German
normative data. Youth were normal weight with BMI less than the 90th percentile,
overweight with BMI from the 90th to 97th percentile, obese with BMI between the 97th to
99.5th percentile and extremely obese with BMI greater than the 99.5th percentile.
Although not a study on a US population, given the size of the cohort and significant
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findings which are especially pertinent to the analysis section of this thesis, it is worthy of
inclusion in this review.
As BMI categories increased, the prevalence of hypertriglyceridemia and reduced
HDL-C increased rapidly. A weaker relationship was present for LDL-C and TC,
however still with high significance (p<0.0001). Holl et al. (2011) reported at least one
abnormal lipid value was found in 13.4% of normal-weight subjects, 24.3% of
overweight patients, 27.9% of obese subjects and 31.9% in the extremely obese group
(p<0.0001). Multiple logistic regression analysis with age and gender as covariates in
addition to BMI categories resulted in significant relative risk (RR) increases according
to BMI category increases. The RRs in comparison to normal weight subjects were as
follows: for reduced HDL-C 1.52 (1.24-1.86) in overweight subjects to 4.39 (2.89-3.97)
in extremely obese subjects, for elevated triglycerides 3.21 (1.18-8.75) in overweight
subjects to 4.86 (1.79-13.18) in extremely obese subjects, for LDL-C the RR increased to
1.94 (1.76-2.14) and for TC to 1.43 (1.31-1.57). If the criterion of at least one abnormal
lipid component was applied the RRs were as follows: 2.07 (1.87-2.28) for overweight
subjects, 2.49 (2.33-2.67) for obese subjects and 3.02 (2.83-3.24) for extremely obese
subjects (Holl et al., 2011).
2.8 Lipid Profile Statistics for US Youth
In an effort to present data that is more relevant to the state of current US youth
lipid levels, this review will focus on recent studies that used data from the National
Health and Nutrition Examination Survey (NHANES). NHANES conducted by the
CDC’s National Center for Health Statistics is a population based survey that examines
nationally representative samples of the US non-institutionalized civilian population.
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Data from NHANES is used to produce national estimates of US health and nutrition
status. Previous National Health and Nutrition Examination Survey (NHANES) studies
have found prevalence of dyslipidemias in children and adolescents of approximately
10% for TC, 26% for triglycerides, 6.6% for LDL-C and 19% for HDL-C (Ford, Li,
Zhao, & Mokdad, 2009; Johnson et al., 2009; Li et al., 2010).
Li and colleagues (2010) compared statistics from a large national insurance
claims database and NHANES 1999-2004 survey data. In analysis of data from the
NHANES cohort an estimated 7.4 million children out of 30 million US children
(weighted frequency with fasting weights, unweighted n=585) had laboratory-defined
dyslipidemia. Laboratory defined dyslipidemia was identified by subjects having at least
one abnormal lipid measure regardless of fasting status. The dyslipidemic measurements
were as follows: TC >200 mg/dl, HDL-C < 35 mg/dl, LDL-C > 130 mg/dl, Triglycerides
> 130 mg/dl, Apolipoprotein A-I, (Apo-A) < 110 mg/dl, or Apolipoprotein B (Apo-B) >
100 mg/dl. With application of mobile examination center (MEC) and fasting weights
this yielded a prevalence of approximately 19.9% (95% CI: 18.3-21.6) to 23.9% (95%
CI: 21.60-26.27) respectively.
Children from 10 to 18 years of age with laboratory defined dyslipidemia were
defined from the Integrated Healthcare Information Services (IHCIS) database for the
years from 2003-2006. The IHCIS database contained 273,064 children with at least one
laboratory lipid value. Of these children 22.9% (n=62451) had laboratory defined
dyslipidemia. A comparison cohort of 10 to 18 year old children was derived from
NHANES survey years 1999-2004. Prevalence for the IHCIS and NHANES cohorts
were similar for triglycerides at 13.2% and 14.2% respectively. Although prevalence of
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overall dyslipidemia was similar, the prevalence for TC, HDL-C and LDL-C was lower
in the IHCIS cohort (TC 9.6% vs. 7.7%, HDL-C 6.7% vs. 4.1%, and LDL-C 7.2% vs.
3.2%). Several theories for this were suggested by the researchers, such as insured status,
health status, interventions and selection bias (Li et al., 2010).
The occurrence of dyslipidemias differed by age and gender amongst the two
cohorts. In the NHANES cohort 10 to11 year old boys displayed the highest prevalence
(58%) of TC compared to 16-18 year old boys with the lowest prevalence (27%).
Whereas TC prevalence for girls in the NHANES group was 45% in the 12 to 13 year old
group and increased to 63% in the 16 to 18 year old girls. The same trends were seen in
the IHCIS cohorts for boys and girls.
For HDL-C, age-related dyslipidemia was reversed, with 10 to 11 year old boys in
the NHANES group at the lowest prevalence (24%) compared to 16 to 18 year boys with
the highest prevalence (57%). This same trend was found in the IHCIS cohort, with the
boys steadily increasing prevalence of dyslipidemic HDL-C with age. There were
differences between the cohorts for girls with dyslipidemic HDL-C. In the NHANES
cohort, dyslipidemic HDL-C decreased as the girls increased in age, whereas in the
IHCIS girl’s cohort this did not occur.
For dyslipidemic triglycerides no age-related changes were found in the NHANES
groups, whereas in the IHCIS cohort boys demonstrated an age-related increase. LDL-C
dyslipidemias were highest in the NHANES 10 to 13 year old boys at 37% compared to
prevalence of 23% in the 16 to 18 year group. Smaller age-related increases were also
found in the IHCIS boys. Girls in both cohorts experienced age-related increases (J. Li
et al., 2010).
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IHCIS cohort data shows a decrease in TC dyslipidemia prevalence in the 12 to 13
year old female group and 14 to 15 year old male group which then begins to rebound
with increasing age. This same trend occurs for LDL-C. Detailed data on the NHANES
cohort was not available for comparison. This change in dyslipidemic TC and LDL-C
prevalence at pubertal ages is consistent with other reported research where TC and LDLC levels decreased by 10 to 20% during puberty (Berenson, Srinivasan, Cresanta, Foster,
& Webber, 1981; Kwiterovich et al., 1997).
Hickman et al. (1998) report on lipid distributions of NHANES data (1988-1994)
which demonstrate similar trends for TC and HDL-C. Children in the 9 to 11 year old
group had the highest mean TC values (171 mg/dl). Females had higher mean TC (167
mg/dl) than males (163 mg/dl). Among racial groups non-Hispanic blacks had
significantly higher mean TC values (170 mg/dl) than non-Hispanic whites (164 mg/dl)
or Mexican Americans (164 mg/dl). Consistent with research on pubertal changes, boys
mean TC levels were significantly less in the 12 to 15 year old group compared to boys 9
to 11 years of age (P < 0.0001). Hickman and colleagues report that mean TC levels
among adolescents decreased by 7 mg/dl (P<0.0001) from 1966 to 1994. This same
trend had previously been reported in adults and is believed to have contributed to the
decrease in mortality from CHD during the same period of time.
HDL-C levels were relatively constant across all age groups, except that boys
mean HDL-C levels decreased significantly from the 9 to 11 age group to the 12 to 15
year old group (P < 0.0001). Overall, the means for HDL-C were similar for both sexes.
Although in females the mean steadily increased with age, whereas in boys the mean was
highest in the 9 to 10 year old group then steadily decreased. Non-Hispanic blacks had
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the highest mean HDL-C levels (55 male, 56 female) compared to non-Hispanic whites
(48 male, 50 female) and Mexican Americans (51 male, 52 female).
The Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk
Reduction in Children and Adolescents include in their report that differences exist
according to race and ethnicity according to geography and that these differences could
be explained in part by socioeconomic status. However, the Expert Panel also points out
“that no group in the U.S. is without a significant prevalence of risk” (Kavey, SimonsMorton, & de Jesus, 2011, p. S4). Several longitudinal cohort studies have included
biracial populations, but longitudinal studies that include Hispanic, Asian and Native
American youth are lacking. The Expert Panel acknowledges that differences exist in
risk factor prevalence according to gender and race and that low socioeconomic status
alone confers substantial risk. However, the “evidence is not adequate” for the Expert
Panel to make recommendations specific to racial or ethnic groups or socioeconomic
status (Kavey et al., 2011, p. S4).
2.9 Reliability of BMI at 85th percentile as a Risk Factor
As previously described, a number of prospective studies have reported tracking of
lipid levels from childhood into adulthood. These studies have found that youth to adult
levels correlate in the range of 0.4 (Daniels et al., 2011). However, Magnussen et al.
(2008) report on the instability of the classification of blood lipid levels in youth, to
predict dyslipidemias in adults. The results of their study show that 60% of youth who
were identified with high risk LDL cholesterol levels did not have abnormal levels as
adults and that most adults who developed low HDL-C did not have dyslipidemic HDL-C
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as youth. These findings contribute to the uncertainty surrounding the approach to and
utility of screening for pediatric dyslipidemias (Magnussen et al., 2011, p. 68).
There is a volume of research that has examined the relationship between
adiposity status and CVD risk factors in youth and which demonstrate positive
correlations. However studies are lacking which assess relationships with dyslipidemia
and BMI at the 85th percentile or greater, the AAP screening criteria in youth. The
majority of research on US children has examined the relationship of obese, not
overweight children and atherosclerosis development through pathology studies, subclinical measures or lipid levels. There are a number of international studies that have
found positive associations between increasing levels of adiposity and more severe
dyslipidemias (Flechtner-Mors et al., 2011; Katzmarzyk, Tremblay, Perusse, Despres, &
Bouchard, 2003; Kim Soh Ye, Hong Kyung Hee, Jang Ki Hyo, Kang Soon Ah, & Choue
Ryo Won, 2005; Takada et al., 1998; Zhai et al., 2004). These studies however, are not
readily generalized to the US pediatric population because many studies were conducted
in Asian populations whose diets are often dissimilar to western foods and because they
used different classification systems for childhood obesity making them difficult to
compare (Cole, Bellizzi, Flegal, & Dietz, 2000).
In a more recent US study Lamb, Ogden, Carroll, Lacher, and Flegal (2011),
analyzed National Health and Nutrition Examination Survey data (1999-2004) for
associations between childhood adiposity and lipid levels. However, due to concern
about the accuracy of BMI as an adiposity measure, researchers instead measured body
fat percentage by dual-energy X-ray absorptiometry. A recent study by Lee and
colleagues (2009) found BMI did not perform well in detecting youth with elevated TC
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or LDL-C levels and called into question the current screening recommendations. The
study population was a NHANES cohort from 1999-2004 survey years. Children 3 to 18
years of old were evaluated for TC and HDL-C levels and 12 to 18 years of age for LDLC and triglycerides. The researchers used receiver operating characteristic (ROC) curves
to evaluate the performance of specific BMI percentiles in predicting dyslipidemias.
ROC analysis for BMIs at the 85th percentile produced area under the curve values of
0.60 for TC, 0.63 for LDL-C, 0.69 for HDL-C and 0.72 for triglycerides.
Lee et al. (2009) also calculated sensitivity, specificity, positive predictive values
(PPVs), and negative predictive values (NPVs) for each lipid factor at different BMI
percentile thresholds. BMI at the 85th percentile as a threshold screening test for TC
dyslipidemia resulted in sensitivity and specificity levels of 53% and 63% respectively,
PPV (14%) and NPV (93%). BMI at the 85th percentile as a screening test for HDL-C
dyslipidemia resulted in sensitivity and specificity of 63% and 65% respectively, PPV
(11%) and NPV (97%).
National expert guidelines recommend BMI at the 85th percentile as the screening
threshold for children and adolescents at risk for dyslipidemia, although research to
support this cutpoint is unclear. Even the Expert Panel Guidelines, with their extensive
research review, do not include studies on this specific relationship. The association of
childhood obesity and cardiovascular disease is well documented. However, additional
research is needed on the relationship of overweight youth and dyslipidemia prevalence.
Cardiovascular disease primary prevention goals for youth address two main areas:
prevention of the development of risk factors and prevention to recognize and manage
youth at risk due to identified risk factors. National expert bodies have developed
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guidelines which delineate children at risk who should receive targeted screening.
Screening guidelines include recommendations to perform serum lipid evaluations on
overweight children. The objective of this thesis is to add to the body of knowledge
concerning the relationship between youth with BMIs at the 85th percentile or greater and
dyslipidemias of TC, HDL-C and non-HDL-C.

CHAPTER III
METHODOLOGY
3.1 Subjects
The data source for this study is the National Health and Nutrition Examination
Survey (NHANES) 2007-2008 and 2009-2010 survey years. NHANES is conducted
through the National Center for Health Statistics of the Centers for Disease Control and
Prevention (CDC). The survey program began in the 1960s and since has evolved into a
continuous program that is conducted every two years. NHANES is highly regarded as
the most comprehensive study of the health and nutrition status of adults and children in
the US. Strict confidentiality is maintained throughout the process. De-identified survey
data are publicly available through the NHANES website. The survey combines
interview and physical examination data from a nationally representative sample of
approximately 5,000 persons each year. The NHANES interview is conducted in the
sample person’s home and includes demographic, socioeconomic, nutrition and healthrelated questions. The examination section is conducted in the mobile examination
center (MEC) by physicians and highly trained medical personnel. The examination
includes medical, dental, and physiological measurements and laboratory tests (Centers
for Disease Control and Prevention, 2012).
NHANES is conducted according to strict protocol and informed consent is
obtained from participants. For each survey cycle, NHANES undergoes National Center
for Health Statistics (NCHS) Research Ethics Review Board Approval. Manuals
developed for interviewer and examiner training are available for public viewing on the
31
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NHANES website. These manuals contain exact details on all policies, procedures and
standards for conducting NHANES survey components (Centers for Disease Control and
Prevention, 2011). Georgia State University Institutional Review Board approval was
granted for this study under Protocol Type H12278, Exempt Review, Category 4.
NHANES uses a complex, multistage, probability sampling design in an effort to
select participants that are representative of the civilian, non-institutionalized US
population. Certain subgroups are oversampled in order to produce reliable statistics.
NHANES oversamples the elderly, Hispanics, African-Americans and low income
persons. In the first stage primary sampling units (PSUs) are selected, which are mostly
single counties or less often groups of contiguous counties. These PSUs are selected
from strata defined by geography and proportions of minority populations. In the second
stage, PSUs are divided into segments such as city blocks. In stage 3, households are
randomly selected from each segment. In stage 4, individuals are randomly chosen to
participate from all persons residing in the household, which results in approximately 1.6
persons per household. Each sample person is assigned a sample weight. This weight is
used to produce an unbiased national estimate (Centers for Disease Control and
Prevention, n.d.).
The original 2007-2008 survey consisted of 10149 sample persons and the 20092010 survey had 10537 sample persons. Complete body measurements were available on
8088 sample persons from the 2007-2008 survey and 8608 sample persons from the
2009-2010 survey. Of these 7387 and 7846 sample persons in the 2007-2008 and 20092010 respective surveys had TC and HDL-C laboratory values. In these survey years,
total cholesterol and HDL-C measurements were conducted on participants beginning at

33
6 years of age. The subset for the present study consists of males and females 6 through
18 years of age who had complete body measurements, TC and HDL-C measurements.
The final data set of combined survey cycles contains 3888 participants of which 2016
are male and 1872 are female.
Beginning in 2007 NHANES employed a new sampling methodology, whereby
other Hispanics were oversampled, not just Mexican-Americans. For example in the
2005-2006 cycle other Hispanics comprised 3.3% of the unweighted sample size,
whereas in 2007-2008 this unweighted sample consisted of 11.7% and 10.8% in 20092010. The like percentages for Mexican-Americans were as follows: 2005-2006
(27.5%), 2007-2008 (21.1%) and 2009-1010 (22.5%). The non-Hispanic black
unweighted sample decreased from 26.3% in 2005-2006, to 21.9% in 2007-2008 and
finally 18.6% in 2009-2010. The non-Hispanic white and other race/ethnicity categories
both had small increases overall. Beginning with the 2007 year survey, changes in the
age domains led to a decrease in the number of participants under 20 years old and an
increase in the number of participants 40 years of age or greater. Also beginning with the
2007-2008 survey, pregnant women were no longer oversampled.
NHANES has been in existence for over 50 years and is renowned as a
comprehensive, national data source for health research interests. NHANES is highly
regarded for adhering to rigorous sampling and data collection processes. Although the
researchers are highly trained and protocols are followed, there is always the possibility
for human and/or technical error. For NHANES in general, selection bias can be present
as subjects are invited to participate and are paid for their participation. As a result, the
cohort of subjects who elect to participate may differ from those that do not. In addition,
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participants do not have to complete all components of the survey. For example
questions may not be answered and laboratory tests refused. The interview component
relies on self-reported information thus lending itself to error with recall or information
bias. There is limitation of race/ethnicity groups. The sampling methodology of
NHANES produces three main groups, Mexican-American, non-Hispanic black and nonHispanic white. The 2007 sampling change has enlarged the other Hispanic sample
group, which allows for stronger analysis of this group. There is no distinct Asian group.
Parameters for exam, laboratory analysis and interview questions vary especially
by age. For example TC and HDL-C testing begins at age 6 years, but triglyceride and
LDL-C testing begins at age 12 years and is restricted to fasting individuals. Since all
participants may not adhere to fasting instructions or falsely report their fasting time, this
could affect the reliability of these lab values. In addition, because a fasting state was
required, noncompliance would further decrease the number of participants who would
be eligible for this component of the exam. In another example, history of hypertension
was initially considered for inclusion in the present study, as a possible confounder, but
was not, because blood pressure interview questions in NHANES are only asked of
participants who are at least 16 years of age.
3.2 Definition of Terms
The variables used in this study are gender, age, race/ethnicity, income, cotinine,
BMI percentile, TC, HDL-C and non-HDL-C. Age is measured in months at the time of
MEC. The study cohort includes youth from 72 through 227 months of age. The lower
threshold of 72 months was selected because this is the minimum age for NHANES
participants to receive TC and HDL-C laboratory analysis. The first age category is 6 to
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8 years of age. The second age category is 9 to 11 years, because this group is
recommended to receive universal screening. The third category is 12 to 15 years of age,
in an effort to capture the pubertal years. The last age category is 16 to 18 years. The
selection of 18 year olds as the upper limit was somewhat arbitrary. The present study is
on children and adolescents. The literature review revealed an assortment of ages studied
including adolescents 18 and 19 years of age. Universal lipid screening is recommended
for persons 18 to 21 years of age and with the guidelines published in December 2011,
the age for universal screening was lowered to 17 years, hence a 17 or 18 year old could
receive lipid screening without having other risk factors. All other age categories
consisted of at least three progressive age years. Including 17 and 18 year olds in the
oldest age category enabled this group to have three progressive years and more closely
resemble the other groups in size.
NHANES uses five race/ethnicity categories: non-Hispanic white, non-Hispanic
black, Mexican-American, other Hispanic and other. The present study is comprised of
four race/ethnicity categories. Three categories are comprised of the same NHANES
subjects for non-Hispanic white, non-Hispanic black, and Mexican-American. The
fourth race/ethnicity category is a merged “other” category derived from the NHANES
other Hispanic and other groups. This fourth merged other category resulted in a subset
of 723 persons out of a total sample group of 3888.
The total household income variable was used as a socioeconomic indicator
variable. Income was divided into five categories by merging NHANES categories. The
resulting five income levels ranged from very low at $0 to $19,999 to high at $100,000 or
greater.
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Tobacco exposure was accounted for by including the laboratory value for
cotinine. According to CDC literature, cotinine levels less than 1 ng/ml indicate nontobacco exposure. A person with cotinine levels ranging from 1 to 10 ng/ml is
environmentally exposed and levels above 10 ng/ml represent tobacco use.
As the focus of the present study is to analyze associations between BMI
categories used in the current guidelines and dyslipidemia, it was imperative to use the
same BMI categories. BMI percentile rankings are categorized according to CDC 2000
pediatric growth chart rankings for obese, overweight, normal and underweight children
and adolescents. The 85th to 94th percentile is the overweight category and threshold for
lipid screening in youth. Children with BMI percentiles at the 95th percentile or greater
are considered obese. Normal or healthy weight children range in the 5th to 84th BMI
percentile and underweight children are less than the 5th BMI percentile.
Three lipid values are used in this analysis, total cholesterol (TC), high-density
lipid cholesterol (HDL-C) and non-high-density lipid cholesterol (non-HDL-C). For
categorical analysis values are categorized into two variables. Total cholesterol less than
200 mg/dl is ‘Acceptable to Borderline’. Total cholesterol at or greater than 200 mg/dl is
‘High’. With HDL-C, the lower values are abnormal, thus a value less than 40 mg/dl is
‘Low’ and values at or greater than 40 mg/dl are ‘Acceptable to Borderline-Low’. NonHDL-C is not included in NHANES surveys, but is easily calculated by subtracting HDLC from TC. Non-HDL-C is ‘High’ with values at or greater than 145 mg/dl and
‘Acceptable to Borderline-High’ if less than 145 mg/dl. The definitions used in this
study for TC, HDL-C and non-HDL-C are consistent with expert panel guidelines from
major national organizations (Kavey, Simons-Morton, & de Jesus, 2011).
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3.3 Statistical Analysis
SAS 9.2 was used for all analysis in this study (SAS Institute Inc., 2012). Survey
documentation for both NHANES two year cycles 2007-2008 and 2009-2010 were
thoroughly reviewed to select needed variables. Data from two 2-year cycles was
combined in order to produce estimates with greater statistical reliability. All of the
selected variables from both 2-year cycles have the same names and definitions hence
data files were appended directly. The appended dataset was sorted by sequence number
and Demographic, Examination and Laboratory data files were merged.
Triglyceride and LDL-C data were considered for inclusion in this study.
However, in NHANES triglycerides and LDL-C lab values are only computed on
participants who are fasting and at least 12 years of age and older. As a result
approximately 76% of the study sample did not have these lab values. Non-HDL-C is
gaining recognition as an important risk marker and could be calculated for inclusion in
this study. Non-HDL-C includes LDL-C and triglycerides, thus considering the
possibility and benefits of including Non-HDL-C in the present study and deficit of a
smaller sample size for triglycerides and LDL-C, triglycerides and LDL-C were not
included in the present study.
Diabetes history was considered, but not included as a covariate. In NHANES, the
interview question for diabetes history and laboratory exam for glycohemogloblin, a
diabetes indicator, are implemented in subjects beginning at 12 years of age. Thus like
triglycerides and LDL-C mentioned above, inclusion of this covariate would substantially
reduce the sample size for this study. It was also noted that there were only 22 positive
responses from subjects in the sample indicating they had a history of diabetes.
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Considering the factors of low diabetes prevalence and that inclusion would necessitate a
substantial reduction in sample size, the decision was made not to include a diabetes
covariate. Pregnancy history questions and laboratory pregnancy testing data are only
available in NHANES on women beginning at 20 years of age, thus pregnant subjects are
not accounted for in this study.
NHANES files were reviewed to check for skip patterns in regards to the variables
selected and none were found. Univariate analysis was conducted for continuous
variables TC, HDL-C, LDL- C and triglycerides to check the distribution and identify
outliers. Although there were some outliers, no outliers were removed for this study,
primarily because their impact was germane to the present study, i.e., extremely high TC
or non-HDL-C or low HDL-C. Multivariate regression analysis was conducted with and
without the inclusion of one extremely low TC variable (TC = 66 mg/dl) and the results
were effectively unchanged, hence this outlier was left in the study sample. The variable
for non-HDL-C was created. The SAS program for CDC Growth Charts was conducted
in order to add the BMI percentile variable to the dataset. Data was recoded into
categorical variables as described in Definition of Terms above.
Descriptive statistics of the study sample are shown in Tables 1, 2 and 3. The
independent-samples t-test is conducted to test equality between mean lipid values for
males and females (Table 4). The sample sizes for males (n=2016) and females (n=1872)
are represented fairly evenly. The large sample size n=3888 compensates for violations
of normality assumption. For all three lipid factors, the F value is small, but significant
to reject equal variances, and both the Pooled (equal) and Satterthwaite (unequal) tstatistics are not significant for mean differences. Satterthwaite t-statistics are included in
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Table 4. Analysis of variance (ANOVA) was completed to examine mean differences of
lipid values for all other categorical variables and results are presented in Tables 5, 6 and
7. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value
(NPV) of BMI percentile risk factor agreement with dyslipidemias were calculated for
the entire sample and stratified by age category with results presented in Tables 8, 9 and
10. Because the focus of this study is the overweight category of children, in contrast to
obese, only the overweight category children were included as positive tests. For
negative tests, only healthy weight children were included.
Simple logistic regression analyses were completed for each covariate and lipid
factor and the results are presented in Table 11. Multiple logistic regression was
completed including all categorical independent variables for each lipid factor and the
results are presented in Table 12.

CHAPTER IV
RESULTS
4.1 Study Sample Demographics
There are 3888 subjects overall in this study sample who comprised the age range
of 6 through 18 years and who had measures for BMI percentile, TC and HDL-C.
Descriptive statistics for the covariates of gender, age, race ethnicity, income, cotinine
levels and BMI percentages are presented in Tables 1, 2 and 3 for each lipid factor
studied. Males represent 52% (n= 2016) and females 48% (n= 1872). The four age
categories (6-8 years, 9-11 years, 12-15 years and 16-18 years) are fairly evenly divided.
There are higher proportions of non-Hispanic whites (31%) and Mexican-Americans
(28%) compared to Non-Hispanic blacks (22%) and other (19%) race ethnic groups.
Household income is categorized into five levels. This subset of the study group is
somewhat smaller at n=3625. The low income group ($20,000 to $44,999) is the largest
at 33%. The moderately high income group ($75,000 to $99,999) is the smallest at 9%.
The subset for cotinine level analysis is slightly smaller at n=3865. Approximately 5% of
the subset are tobacco users and 11% are environmentally exposed.
Twenty-two percent (n=840) of the sample is obese. Overweight youth comprise
17% of the study population (n=652). Fifty-nine percent (n=2283) of the sample are a
healthy weight and 3% (n=113) are underweight. As depicted in Table 2 dyslipidemic
HDL-C is the most prevalent abnormal lipid factor with 52% of obese children and
adolescents at abnormal levels. Although underweight youth have lower levels of
dyslipidemia, they do not always have the lowest prevalence per lipid factor. The lowest
40
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prevalence for dyslipidemias occurs for non-HDL-C in the underweight group (4%), but
for TC and HDL-C the lowest prevalence is in the healthy weight group at 6% and 18%
respectively. Abnormality of lipid prevalence progressively increases as BMI percentile
categories transition from healthy weight to obese for all three lipid factors.
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Table 1
Total Cholesterol (TC) Values Descriptive Statistics of Study Sample
Variables

Acceptable to
Borderline-High <200
mg/dl

High >=200
mg/dl

Total

Gender (N=3888)
Male
Female
Total

1851 (91.82%)
1739 (92.90%)
3590 (92.34%)

165 (8.18%)
133 (7.10%)
298 (7.66%)

2016 (51.85%)
1872 (48.15%)
3888

Age (N=3888)
6-8 years
9-11 years
12-15 years
16-18 years
Total

844 (91.74%)
916 (90.60%)
1038 (94.36%)
792 (92.42%)
3590 (92.34%)

76 (8.26%)
95 (9.40%)
62 (5.64%)
65 (7.58%)
298 (7.66%)

920 (23.66%)
1011 (26.00%)
1100 (28.29%)
857 (22.04%)
3888

BMI Percentiles (N=3888)
Underweight <5th Percentile
Healthy Weight 5th – 84th Percentile
Overweight 85th – 94th Percentile
Obese >=95th Percentile
Total

103 (91.15%)
2148 (94.09%)
593 (90.95%)
746 (88.81%)
3590 (92.34%)

10 (8.85%)
135 (5.91%)
59 (9.05%)
94 (11.19%)
298 (7.66%)

113 (2.91%)
2283 (58.72%)
652 (16.77%)
840 (21.60%)
3888

Race Ethnicity (N=3888)
Non-Hispanic white
Non-Hispanic black
Mexican-American
Other
Total

1116 (92.69%)
804 (91.99%)
1012 (93.10%)
658 (91.01%)
3590 (92.34%)

88 (7.31%)
70 (8.01%)
75 (6.90%)
65 (8.99%)
298 (7.66%)

1204 (30.97%)
874 (22.48%)
1087 (27.96%)
723 (18.60%)
3888

Household Income (N=3625)
$0 to $19,999
$20,000 to $44,999
$45,000 to $74,999
$75,000 to $99,999
$100,000+
Total

771 (92.56%)
1105 (91.78%)
692 (93.01%)
303 (92.10%)
478 (92.82%)
3349 (92.39%)

62 (7.44%)
99 (8.22%)
52 (6.99%)
26 (7.90%)
37 (7.18%)
276 (7.61%)

833 (22.98%)
1204 (33.21%)
744 (20.52%)
329 (9.08%)
515 (14.21%)
3625

3012 (92.42%)
386 (92.12%)

247 (7.58%)
33 (7.88%)

3259 (84.32%)
419 (10.84%)

170 (90.91%)
3568 (92.32%)

17 (9.09%)
297 (7.68%)

187 (4.84%)
3865

Cotinine Levels (N=3865)
Non-Tobacco Exposure <1 ng/ml
Environmental Tobacco Exposure 1
to 10 ng/ml
Tobacco User >10 ng/ml
Total
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Table 2
High-Density Lipoprotein Cholesterol (HDL-C) Values Descriptive Statistics of Study Sample
Variables

Acceptable to
Borderline-Low
>=40 mg/dl

Low <40 mg/dl

Total

Gender (N=3888)
Male
Female
Total

1446 (71.73%)
1377 (73.56%)
2823 (72.61%)

570 (28.27%)
495 (26.44%)
1065 (27.39%)

2016 (51.85%)
1872 (48.15%)
3888

Age (N=3888)
6-8 years
9-11 years
12-15 years
16-18 years
Total

726 (78.91%)
746 (73.79%)
787 (71.55%)
564 (65.81%)
2823 (72.61%)

194 (21.09%)
265 (26.21%)
313 (28.45%)
293 (34.19%)
1065 (27.39%)

920 (23.66%)
1011 (26.00%)
1100 (28.29%)
857 (22.04%)
3888

BMI Percentiles (N=3888)
Underweight <5th Percentile
Healthy Weight 5th – 84th Percentile
Overweight 85th – 94th Percentile
Obese >=95th Percentile
Total

92 (81.42%)
1875 (82.13%)
450 (69.02%)
406 (48.33%)
2823 (72.61%)

21 (18.58%)
408 (17.87%)
202 (30.98%)
434 (51.67%)
1065 (27.39%)

113 (2.91%)
2283 (58.72%)
652 (16.77%)
840 (21.60%)
3888

Race Ethnicity (N=3888)
Non-Hispanic white
Non-Hispanic black
Mexican-American
Other
Total

851 (70.68%)
710 (81.24%)
747 (68.72%)
515 (71.23%)
2823 (72.61%)

353 (29.32%)
164 (18.76%)
340 (31.28%)
208 (28.77%)
1065 (27.39%)

1204 (30.97%)
874 (22.48%)
1087 (27.96%)
723 (18.60%)
3888

Household Income (N=3625)
$0 to $19,999
$20,000 to $44,999
$45,000 to $74,999
$75,000 to $99,999
$100,000+
Total

584 (70.11%)
857 (71.18%)
539 (72.45%)
248 (75.38%)
409 (79.42%)
2637 (72.74%)

249 (29.89%)
347 (28.82%)
205 (27.55%)
81 (24.62%)
106 (20.58%)
988 (27.26%)

833 (22.98%)
1204 (33.21%)
744 (20.52%)
329 (9.08%)
515 (14.21%)
3625

2404 (73.76%)
295 (70.41%)

855 (26.24%)
124 (29.59%)

3259 (84.32%)
419 (10.84%)

107 (57.22%)
2806 (72.60%)

80 (42.78%)
1059 (27.40%)

187 (4.84%)
3865

Cotinine Levels (N=3865)
Non-Tobacco Exposure <1 ng/ml
Environmental Tobacco Exposure 1
to 10 ng/ml
Tobacco User >10 ng/ml
Total
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Table 3
Non-High-Density Lipoprotein-Cholesterol (Non-HDL-C) Values Descriptive Statistics of Study
Sample
Variables

Acceptable to
Borderline-Low
>=40 mg/dl

Low <40 mg/dl

Total

Gender (N=3888)
Male
Female
Total

1816 (90.08%)
1717 (91.72%)
3533 (90.87%)

200 (9.92%)
155 (8.28%)
355 (9.13%)

2016 (51.85%)
1872 (48.15%)
3888

Age (N=3888)
6-8 years
9-11 years
12-15 years
16-18 years
Total

856 (93.04%)
906 (89.61%)
1012 (92.00%)
759 (88.56%)
3533 (90.87%)

64 (6.96%)
105 (10.39%)
88 (8.00%)
98 (11.44%)
355 (9.13%)

920 (23.66%)
1011 (26.00%)
1100 (28.29%)
857 (22.04%)
3888

BMI Percentiles (N=3888)
Underweight <5th Percentile
Healthy Weight 5th – 84th Percentile
Overweight 85th – 94th Percentile
Obese >=95th Percentile
Total

108 (95.58%)
2160 (94.61%)
582 (89.26%)
683 (81.31%)
3533 (90.87%)

5 (4.42%)
123 (5.39%)
70 (10.74%)
157 (18.69%)
355 (9.13%)

113 (2.91%)
2283 (58.72%)
652 (16.77%)
840 (21.60%)
3888

Race Ethnicity (N=3888)
Non-Hispanic white
Non-Hispanic black
Mexican-American
Other
Total

1073 (89.12%)
816 (93.36%)
989 (90.98%)
655 (90.59%)
3533 (90.87%)

131 (10.88%)
58 (6.64%)
98 (9.02%)
68 (9.41%)
355 (9.13%)

1204 (30.97%)
874 (22.48%)
1087 (27.96%)
723 (18.60%)
3888

Household Income (N=3625)
$0 to $19,999
$20,000 to $44,999
$45,000 to $74,999
$75,000 to $99,999
$100,000+
Total

752 (90.28%)
1080 (89.70%)
686 (92.20%)
303 (92.10%)
474 (92.04%)
3295 (90.90%)

81 (9.72%)
124 (10.30%)
58 (7.80%)
26 (7.90%)
41 (7.96%)
330 (9.10%)

833 (22.98%)
1204 (33.21%)
744 (20.52%)
329 (9.08%)
515 (14.21%)
3625

2972 (91.19%)
381 (90.93%)

287 (8.81%)
38 (9.07%)

3259 (84.32%)
419 (10.84%)

158 (84.49%)
3511 (90.84%)

29 (15.51%)
354 (9.16%)

187 (4.84%)
3865

Cotinine Levels (N=3865)
Non-Tobacco Exposure <1 ng/ml
Environmental Tobacco Exposure 1
to 10 ng/ml
Tobacco User >10 ng/ml
Total
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Table 4 depicts the Independent-Samples t-test analysis to compare mean values of
the three lipid factors studied among males and females. There are no significant
differences in the mean values for any of the three lipids between males and females.
Table 4
Lipid Factors Independent-Samples t-Test (N=3888)
Lipid Variable
Total Cholesterol
Male
Female
HDL-C
Male
Female

Mean (95% CI)

t Value
-1.27

Pr > [t]
0.2037

-0.26

0.7975

-1.17

0.2430

158.7 (157.5, 159.9)
159.8 (158.6, 161.0)

52.6 (52.0, 53.2)
52.7 (52.1, 53.2)

Non-HDL-C
Male
Female

106.1 (104.9, 107.4)
107.1 (106.0, 108.3)

Male (N=2016)
Female (N=1872)

Tables 5, 6 and 7 are an ANOVA analysis to examine the differences of the mean
lipid values for each multi-categorical independent variable. ANOVA analysis for total
cholesterol mean values is presented in Table 5. There are significant mean differences
of TC values according to age and BMI percentile categories. Children 6 to 8 years of
age have mean TC values approximately 6 mg/dl higher than youth in the 12 to 15 year
age group. Youth in the 9 to 11 year old group have mean levels of TC significantly
higher than both older groups. The mean TC value for healthy weight children is
approximately 3 mg/dl lower than overweight children and approximately 5 mg/dl lower
than obese youth.
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Table 5
Total Cholesterol (TC) Analysis of Variance
Variable Categorical Comparisons
BMI Percentiles (N=3888)
Healthy Weight – Underweight
Healthy Weight – Overweight
Healthy Weight – Obese
Overweight – Underweight
Overweight – Obese
Obese – Underweight
Age (N=3888)
Age 6-8 years - Age 9-11 years
Age 6-8 years - Age 12-15 years
Age 6-8 years - Age 16-18 years
Age 9-11 years - Age 12-15 years
Age 9-11 years - Age 16-18 years
Age 12-15 years - Age 16-18 years

Difference Between Means
(95% CI)

8.91

<.0001

13.70

<.0001

1.07

0.3586

1.81

0.1246

2.37

0.0937

-1.159 (-4.373, 2.054)
5.891 (2.741, 9.042)***
2.770 (-0.578, 6.118)
7.051 (3.978, 10.123)***
3.930 (0.655, 7.204)***
-3.121 (-6.334, -0.092)

0.324 (-2.825, 3.473)
1.197 (-1.768, 4.162)
-1.145 (-4.480, 2.189)
0.873 (-2.346, 4.093)
-1.469 (-5.031, 2.093)
-2.342 (-5.743, 1.059)

Household Income (N=3625)
0 to $19,999 - $20,000 to $44,999
0 to $19,999 - $45,000 to $74,999
0 to $19,999 - $75,000 to $99,999
0 to $19,999 - $100,000+
$20,000 to $44,999 - $45,000 to $74,999
$20,000 to $44,999 - $75,000 to $99,999
$20,000 to $44,999 - $100,000+
$45,000 to $74,999 – $75,000 to $99,999
$45,000 to $74,999 - $100,000+
$75,000 to $99,999 - $100,000+

-2.333 (-5.722, 1.056)
0.280 (-3.513, 4.074)
-2.813 (-7.709, 2.084)
-1.916 (-6.132, 2.300)
2.613 (-0.894, 6.120)
-0.480 (-5.158, 4.199)
0.417 (-3.543 4.377)
-3.093 (-8.072, 1.886)
-2.196 (-6.507, 2.115)
0.897 (-4.411, 6.204)

***comparisons significant at the 0.05 level

Pr > F

-2.7069 (-9.5156, 4.1018)
-3.4511 (-6.5883, -0.3139)***
-5.4068 (-8.2579, -2.5558)***
0.7442 (-6.4549, 7.9433)
-1.9557 (-5.6432, 1.7318)
2.6999 (-4.3792, 9.7790)

Race Ethnicity (N=3888)
Non-Hispanic white - Non-Hispanic black
Non-Hispanic white - Mexican-American
Non-Hispanic white – Other
Non-Hispanic black - Mexican-American
Non-Hispanic black – Other
Mexican-American – Other

Cotinine Levels (N=3865)
Non-Tobacco –Environmental Tobacco
Non-Tobacco - Tobacco User
Environmental Tobacco – Tobacco User

F Value

1.7298 (-1.6272, 5.0867)
3.9416 (-0.9223, 8.8055)
2.2118 (-3.4766, 7.9003)
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As depicted in Table 6, all five multi-categorical covariates examined for HDL-C
mean differences have significant findings as described to follow. Six to 8 year olds have
higher mean HDL-C values than 12 to 18 year olds. HDL-C mean values of 16 to 18
year old adolescents are lower than youth 9 through 15 years of age. There are
significant differences in HDL-C mean values according to participant BMI percentiles,
which paralleled increasing weight categories. The most extreme is a decrease of 12
mg/dl in obese compared to underweight youth. The mean HDL-C of non-Hispanic
whites and Mexican-Americans is approximately 5 mg/dl lower than non-Hispanic
blacks. The other race ethnicity group has a mean HDL-C value that is approximately 4
mg/dl lower than non-Hispanic blacks. Study youth in households at the lowest income
have lower HDL-C mean levels when compared to study participants in the higher
income groups. The mean values of HDL-C are 4 mg/dl lower in tobacco users
compared to those environmentally exposed to tobacco, and 5 mg/dl lower in tobacco
users in comparison to non-tobacco users.
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Table 6
High-Density Lipoprotein Cholesterol (HDL-C) Analysis of Variance
Variable Categorical Comparisons
BMI Percentiles (N=3888)
Healthy Weight – Underweight
Healthy Weight – Overweight
Healthy Weight – Obese
Overweight – Underweight
Overweight – Obese
Obese - Underweight

Difference Between Means
(95% CI)

-1.2487 (-0.2376, 2.7351)
2.4499 (0.9924, 3.9073)***
4.0192 (2.4705, 5.5679)***
1.2012 (-0.2201, 2.6224)
2.7705 (1.2558, 4.2852)***
1.5693 (0.0830, 3.0556)***

Race Ethnicity (N=3888)
Non-Hispanic white - Non-Hispanic black
Non-Hispanic white - Mexican-American
Non-Hispanic white - Other
Non-Hispanic black - Mexican-American
Non-Hispanic black - Other
Mexican-American - Other

-4.9946 (-6.4345, -3.5548)***
0.1752 (-1.1804, 1.5309)
-1.1225 (-2.6470, 0.4019)
5.1698 (3.6978, 6.6419)***
3.8721 (2.2432, 5.5010)***
-1.2978 (-2.8527, 0.2572)

Household Income (N=3625)
0 to $19,999 - $20,000 to $44,999
0 to $19,999 - $45,000 to $74,999
0 to $19,999 - $75,000 to $99,999
0 to $19,999 - $100,000+
$20,000 to $44,999 - $45,000 to $74,999
$20,000 to $44,999 - $75,000 to $99,999
$20,000 to $44,999 - $100,000+
$45,000 to $74,999 – $75,000 to $99,999
$45,000 to $74,999 - $100,000+
$75,000 to $99,999 - $100,000+

-1.1062 (-2.6724, 0.4599)
-1.2174 (-2.9704, 0.5355)
-2.2689 (-4.5316, 0.0061)***
-2.0847 (-4.0327, -0.1368)***
-0.1112 (-1.7317, 1.5094)
-1.1626 (-3.3244, 0.9992)
-0.9785 (-2.8082, 0.8512)
-1.0514 (-3.3522, 1.2494)
-0.8673 (-2.8593, 1.1247)
0.1841 (-2.2685, 2.6367)

***comparisons significant at the 0.05 level

Pr > F

161.13

<.0001

16.41

<.0001

34.30

<.0001

3.03

0.0166

15.18

<.0001

-2.0747 (-5.0581, 0.9088)
4.8203 (3.4456, 6.1950)***
10.2800 (9.0308, 11.5293)***
-6.8950 (-10.0495, -3.7404)***
5.4598 (3.8439, 7.0756)***
-12.3547 (-15.4567, -9.2527)***

Age (N=3888)
Age 6-8 years - Age 9-11 years
Age 6-8 years - Age 12-15 years
Age 6-8 years - Age 16-18 years
Age 9-11 years - Age 12-15 years
Age 9-11 years - Age 16-18 years
Age 12-15 years - Age 16-18 years

Cotinine Levels (N=3865)
Non-Tobacco –Environmental Tobacco
Non-Tobacco - Tobacco User
Environmental Tobacco – Tobacco User

F Value

1.1539 (-0.3932, 2.7010)
5.1123 (2.8706, 7.3539)***
3.9583 (1.3367, 6.5800)***
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ANOVA analysis for non-HDL-C value mean differences is presented in Table 7.
Significant findings are in the age, BMI percentile and race ethnicity groups as follows.
Children 12 to 15 years old have lower non-HDL-C mean values in comparison to all the
other age groups. Non-HDL-C mean values are progressively higher in parallel to
increasing BMI percentile groups for all comparisons, except the underweight to healthy
weight comparison which lacks significance. Non-Hispanic black participants have mean
values approximately 4 to 5 mg/dl lower than all other race ethnicity study groups.
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Table 7
Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Analysis of Variance
Variable Categorical Comparisons
BMI Percentiles (N=3888)
Healthy Weight – Underweight
Healthy Weight – Overweight
Healthy Weight – Obese
Overweight – Underweight
Overweight – Obese
Obese – Underweight
Age (N=3888)
Age 6-8 years - Age 9-11 years
Age 6-8 years - Age 12-15 years
Age 6-8 years - Age 16-18 years
Age 9-11 years - Age 12-15 years
Age 9-11 years - Age 16-18 years
Age 12-15 years - Age 16-18 years
Race Ethnicity (N=3888)
Non-Hispanic white - Non-Hispanic black
Non-Hispanic white - Mexican-American
Non-Hispanic white - Other
Non-Hispanic black - Mexican-American
Non-Hispanic black - Other
Mexican-American - Other

Difference Between Means
(95% CI)

Pr > F

77.10

<.0001

9.14

<.0001

7.85

<.0001

1.19

0.3121

0.27

0.7666

-0.6322 (-7.1869, 5.9225)
-8.2714 (-11.2916, -5.2512)***
-15.6869 (-18.4316, -12.9421)***
7.6392 (0.7086, 14.5698)***
-7.4155 (-10.9654, -3.8655)***
15.0546 (8.2396, 21.8697)***

-2.408 (-5.587, 0.771)
3.441 (0.324, 6.558)***
-1.249 (-4.561, 2.063)
5.849 (2.810, 8.889)***
1.159 (-2.080, 4.399)
-4.690 (-7.869, -1.511)***

5.318 (2.216, 8.420)***
1.022 (-1.899, 3.942)
-0.023 (-3.307, 3.261)
-4.297 (-7.468, -1.126)***
-5.341 (-8.850, -1.832)***
-1.044 (-4.394, 2.305)

Household Income (N=3625)
0 to $19,999 - $20,000 to $44,999
0 to $19,999 - $45,000 to $74,999
0 to $19,999 - $75,000 to $99,999
0 to $19,999 - $100,000+
$20,000 to $44,999 - $45,000 to $74,999
$20,000 to $44,999 - $75,000 to $99,999
$20,000 to $44,999 - $100,000+
$45,000 to $74,999 – $75,000 to $99,999
$45,000 to $74,999 - $100,000+
$75,000 to $99,999 - $100,000+

-1.227 (-4.576, 2.122)
1.498 (-2.251, 5.246)
-0.544 (-5.383, 4.295)
0.169 (-3.997, 4.334)
2.724 (-0.741, 6.190)
0.683 (-3.940, 5.306)
1.395 (-2.517, 5.308)
-2.041 (-6.962, 2.879)
-1.329 (-5.589, 2.931)
0.713 (-4.532, 5.957)

Cotinine Levels (N=3865)
Non-Tobacco –Environmental Tobacco
Non-Tobacco - Tobacco User
Environmental Tobacco – Tobacco User

0.5758 (-2.7415, 3.8932)
-1.1707 (-5.9772, 3.6359)
-1.7465 (-7.3679, 3.8749)

***comparisons significant at the 0.05 level

F Value
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4.2 Test Agreement
Agreement between the overweight BMI category (85th to less than the 95th
percentile) as a test/predictor and dyslipidemia of the three lipid factors is presented in
Tables 8, 9 and 10. The results for TC dyslipidemia as the positive outcome/disease are
depicted in Table 8. The sensitivity of overweight children as positive testers is low and
ranges from 26.19 to 36.84%. The highest sensitivity (36.84%) is in the 9 to 11 year old
age group. The specificity is moderate at 78.37%. The PPV is low with the highest PPV
in the 9 to 11 year old group at 12.07%. The NPV is high at 94.09%.
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Table 8
Agreement between Overweight BMI Percentile as a Risk Factor and Dyslipidemia of Total
Cholesterol in study participants (N = 2935)
Overweight
BMI
Percentile
Risk Factor

Total Cholesterol
Dyslipidemia

Positive¹
Negative²

6 to 18 years old
Positive³ Negative⁴
59
593
135
2148

Positive¹
Negative²

6 to 8 years old
Positive³ Negative⁴
14
114
37
540

Positive¹
Negative²

9 to 11 years old
Positive³ Negative⁴
21
153
36
534

Positive¹
Negative²

12 to 15 years old
Positive³ Negative⁴
11
183
31
607

Positive¹
Negative²

16 to 18 years old
Positive³ Negative⁴
13
143
31
467

Sensitivity
(95% CI)

Specificity
(95% CI)

Positive
Predictive
Value
(95% CI)

Negative
Predictive
Value
(95% CI)

30.41%
(0.240,
0.374)

78.37%
(0.768,
0.799)

9.05%
(0.070,
0.115)

94.09%
(0.930,
0.950)

27.45%
(0.159,
0.417)

82.57%
(0.794,
0.854)

10.94%
(0.061,
0.177)

93.59%
(0.913,
0.955)

36.84%
(0.245,
0.507)

77.73%
(0.744,
0.808)

12.07%
(0.076,
0.179)

93.68%
(0.914,
0.955)

26.19%
(0.139,
0.420)

76.84%
(0.737,
0.797)

5.67%
(0.029,
0.099)

95.14%
(0.932,
0.967)

29.55%
(0.168,
0.452)

76.56%
(0.730,
0.799)

8.33%
(0.045,
0.138)

93.78%
(0.913,
0.957)

¹Overweight BMI = 85th to <95th percentile
²Healthy Weight BMI = 5th to < 85th percentile
³Total Cholesterol values >= 200 mg/dl
⁴Total Cholesterol values <200 mg/dl
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Test agreement statistics for HDL-C are presented in Table 9. Sensitivity is
highest in the 12 to 15 year old children at 38.76%. Although the PPV (30.98%) is still
low for this lipid factor, it is much higher than TC and non-HDL-C. The highest PPV is
with the 16 to 18 year old group at 37.82%. Specificity and NPV is approximately 80%
overall.
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Table 9
Agreement between Overweight BMI Percentile as a Risk Factor and Dyslipidemia of High
Density Lipoprotein-Cholesterol (HDL-C) in study participants (N = 2935)
Overweight
BMI
Percentile
Risk Factor

HDL-C Dyslipidemia

Positive¹
Negative²

6 to 18 years old
Positive⁵ Negative⁶
202
450
408
1875

Positive¹
Negative²

6 to 8 years old
Positive⁵ Negative⁶
23
105
84
493

Positive¹
Negative²

9 to 11 years old
Positive⁵ Negative⁶
51
123
94
476

Positive¹
Negative²

12 to 15 years old
Positive⁵ Negative⁶
69
125
109
529

Positive¹
Negative²

16 to 18 years old
Positive⁵ Negative⁶
59
97
121
377

Sensitivity
(95% CI)

Specificity
(95% CI)

Positive
Predictive
Value
(95% CI)

Negative
Predictive
Value
(95% CI)

33.11%
(0.294,
0.370)

80.65%
(0.790,
0.822)

30.98%
(0.275,
0.347)

82.13%
(0.805,
0.837)

21.50%
(0.141,
0.304)

82.44%
(0.792,
0.854)

17.97%
(0.117,
0.257)

85.44%
(0.823,
0.882)

35.17%
(0.274,
0.435)

79.47%
(0.760,
0.826)

29.31%
(0.227,
0.367)

83.51%
(0.802,
0.865)

38.76%
(0.316,
0.463)

80.89%
(0.777,
0.838)

35.57%
(0.288,
0.427)

82.92%
(0.798,
0.858)

32.78%
(0.260,
0.402)

79.54%
(0.756,
0.831)

37.82%
(0.302,
0.459)

75.70%
(0.717,
0.794)

¹Overweight BMI = 85th to <95th percentile
²Healthy Weight BMI = 5th to < 85th percentile
⁵HDL-C values <40 mg/dl
⁶HDL-C values >=40 mg/dl
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Table 10 includes results of test agreement between children in the overweight
BMI percentile and dyslipidemia of non-HDL-C. Nine to 11 year old children have the
highest sensitivity (41.51%) and PPV (12.64%). The specificity and NPV are 78.77%
and 94.61% respectively.
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Table 10
Agreement between Overweight BMI Percentile as a Risk Factor and Dyslipidemia of Non-High
Density Lipoprotein Cholesterol (Non-HDL-C) in study participants (N = 2935)
Overweight
BMI
Percentile
Risk Factor

Non-HDL
Dyslipidemia

Positive¹
Negative²

6 to 18 years old
Positive⁷ Negative⁸
70
582
123
2160

Positive¹
Negative²

6 to 8 years old
Positive⁷ Negative⁸
14
114
20
557

Positive¹
Negative²

9 to 11 years old
Positive⁷ Negative⁸
22
152
31
539

Positive¹
Negative²

12 to15 years old
Positive⁷ Negative⁸
18
176
32
606

Positive¹
Negative²

16 to18 years old
Positive⁷ Negative⁸
16
140
40
458

Sensitivity
(95% CI)

Specificity
(95% CI)

Positive
Predictive
Value
(95% CI)

Negative
Predictive
Value
(95% CI)

36.27%
(0.295,
0.435)

78.77%
(0.772,
0.803)

10.74%
(0.085,
0.134)

94.61%
(0.936,
0.955)

41.18%
(0.247,
0.593)

83.01%
(0.800,
0.858)

10.94%
(0.061,
0.177)

96.53%
(0.947,
0.979)

41.51%
(0.281,
0.559)

78.00%
(0.747,
0.810)

12.64%
(0.081,
0.185)

94.56%
(0.924,
0.963)

36.00%
(0.229,
0.508)

77.49%
(0.744,
0.804)

9.28%
(0.056,
0.143)

94.98%
(0.930,
0.965)

28.57%
(0.173,
0.422)

76.59%
(0.730,
0.799)

10.26%
(0.060,
0.161)

91.97%
(0.892,
0.942)

¹Overweight BMI = 85th to <95th percentile
²Healthy Weight BMI = 5th to < 85th percentile
⁷Non-HDL-C values >=145 mg/dl
⁸Non-HDL-C values <145 mg/dl
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4.3 Simple Logistic Regression
Univariate logistic regression for each covariate is presented in Table 11. Analysis
for dyslipidemic TC reveals two covariates, age and BMI percentiles have significant
findings. Twelve to 15 year old youth are at decreased risk (OR= 0.7) for dyslipidemic
TC in comparison to 6 to 8 year old children. Overweight and obese children are
respectively 1.6 and 2.0 times more likely to have abnormal TC values compared to
healthy weight youth.
Significant findings for dyslipidemic HDL-C are numerous. As children progress
into higher age categories their odds ratios (OR= 1.3 to 1.9) for dyslipidemic HDL-C
increase. Overweight and obese youth are at increased risk (OR= 2.1 and 4.9
respectively) for abnormal HDL-C. Non-Hispanic blacks have less risk (OR= 0.6) in
comparison to non-Hispanic whites. Children from households in the highest income
group are 40% less likely to have dyslipidemic HDL-C than those from the lowest
income category. Lastly, tobacco users have 2.1 times the risk for abnormal HDL-C
compared to those not exposed to tobacco.
There are four covariates with significant findings for dyslipidemic non-HDL-C,
age, BMI percentiles, race ethnicity and tobacco exposure. Two age categories of
children, 9 to 11 year olds and 16 to 18 year olds are at increased risk (OR = 1.6 and 1.7
respectively) for abnormal non-HDL-C. The overweight and obese youth again display
increased risk (OR = 2.1 and 4.0 respectively) in comparison to normal weight children.
The race ethnicity category of non-Hispanic black demonstrates a protective effect (OR =
0.6) for non-HDL-C dyslipidemia. Tobacco users have 1.9 times the risk for abnormal
non-HDL-C.
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Table 11
Simple Logistic Regression for Dyslipidemias
Categorical Variables
BMI Percentiles (N=3888)
Healthy Weight¹ (Ref)
Underweight²
Overweight³
Obese⁴

Total Cholesterol
OR (95% CI)

HDL-C
OR (95% CI)

Non-HDL-C
OR (95% CI)

1.55 (0.79, 3.03)
1.58 (1.15, 2.18)***
2.01 (1.52, 2.64)***

1.05 (0.65, 1.71)
2.06 (1.69, 2.51)***
4.91 (4.13, 5.84)***

0.81 (0.33, 2.03)
2.11 (1.55, 2.87)***
4.04 (3.14, 5.19)***

Gender (N=3888)
Male (Ref)
Female

0.86 (0.68, 1.09)

0.91 (0.79, 1.05)

0.82 (0.66, 1.02)

Age (N=3888)
6 to 8 years (Ref)
9 to 11 years
12 to 15 years
16 to 18 years

1.15 (0.84, 1.58)
0.66 (0.47, 0.94)***
0.91 (0.65, 1.29)

1.33 (1.08, 1.64)***
1.49 (1.21, 1.83)***
1.94 (1.57, 2.40)***

1.55 (1.12, 2.14)***
1.16 (0.83, 1.63)
1.73 (1.24, 2.40)***

Race Ethnicity (N=3888)
Non-Hispanic white (Ref)
Non-Hispanic black
Mexican-American
Other

1.10 (0.80, 1.53)
0.94 (0.68, 1.29)
1.25 (0.90, 1.75)

0.56 (0.45, 0.69)***
1.10 (0.92, 1.31)
0.97 (0.80, 1.19)

0.58 (0.42, 0.80)***
0.81 (0.62, 1.07)
0.85 (0.63, 1.16)

Household Income (N=3625)
$0 to $19,999 (Ref)
$20,000 to $44,999
$45,000 to $74,999
$75,000 to $99,999
$100,000+

1.11 (0.80, 1.55)
0.93 (0.64, 1.37)
1.07 (0.66, 1.72)
0.96 (0.63, 1.47)

0.95 (0.78, 1.15)
0.89 (0.72, 1.11)
0.77 (0.57, 1.03)
0.61 (0.47, 0.79)***

1.07 (0.79, 1.43)
0.79 (0.55, 1.12)
0.80 (0.50, 1.26)
0.80 (0.54, 1.19)

Tobacco Exposure (N=3865)
Non-Exposed⁵ (Ref)
Environmental Exposure⁶
Tobacco User⁷

1.04 (0.71, 1.52)
1.22 (0.73, 2.04)

1.18 (0.95, 1.48)
2.10 (1.56, 2.84)***

1.03 (0.72, 1.47)
1.90 (1.26, 2.88)***

***ORs significant at the 0.05 level
Note: Dyslipidemias are defined as TC >=200 mg/dl, HDL-C < 40 mg/dl, and non-HDL-C >=145 mg/dl
th
th
¹ Healthy Weight = BMI 5 – 84 percentile
th
²Underweight =BMI <5 percentile
th
th
³Overweight = BMI 85 to 94 percentile
th
⁴Obese = BMI >= 95 percentile
⁵Non-Tobacco Exposure = Cotinine level <1 ng/ml
⁶Environmental Tobacco Exposure = Cotinine level 1 to 10 ng/ml
⁷Tobacco User = Cotinine level > 10 ng/ml
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4.4 Multivariate Logistic Regression
Multiple logistic regression analysis is conducted with inclusion of all independent
covariates as depicted in Table 12. There are 3605 participants in the sample who have
data elements for all dependent and independent variables. For TC dyslipidemia the
same covariates remain significant with essentially no change in their odds ratios. There
is also very little change in the ORs of independent variables in the regression analysis
for HDL-C dyslipidemia, with the exception of cotinine. After controlling for all other
categorical variables, tobacco users risk for dyslipidemic HDL-C decreases from 110 to
62%.
Analyses for non-HDL-C dyslipidemia reveal a small increase in the ORs from the
univariate to the multiple regression for obese youth, 4.0 to 4.3 respectively. MexicanAmerican youth are 30% less likely (OR = 0.7) to have abnormal non-HDL-C in the
multiple regression, whereas in the univariate analysis this OR was not significant. Also
after controlling for other variables, the protective effect of non-Hispanic black race
ethnicity status is increased slightly from OR= 0.6 to 0.5. The increased risk associated
with tobacco use is no longer significant in the multiple regression analysis. All other
significant ORs for non-HDL-C dyslipidemia remain essentially the same.
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Table 12
Multiple Logistic Regression for Dyslipidemias (N = 3605)
Categorical Variables
BMI Percentiles
Healthy Weight¹ (Ref)
Underweight²
Overweight³
Obese⁴

Total Cholesterol
OR (95% CI)

HDL-C
OR (95% CI)

Non-HDL-C
OR (95% CI)

1.63 (0.83, 3.22)
1.53 (1.09, 2.16)***
2.11 (1.58, 2.81)***

0.93 (0.55, 1.55)
1.98 (1.60, 2.44)***
5.04 (4.19, 6.07)***

0.81 (0.32, 2.03)
2.19 (1.59, 3.04)***
4.28 (3.28, 5.58)***

0.86 (0.67, 1.11)

0.97 (0.83, 1.13)

0.85 (0.67, 1.08)

1.18 (0.85, 1.65)
0.66 (0.46, 0.95)***
0.86 (0.59, 1.26)

1.33 (1.05, 1.68)***
1.52 (1.21, 1.90)***
2.01 (1.57, 2.57)***

1.60 (1.13, 2.27)***
1.22 (0.85, 1.74)
1.66 (1.15, 2.41)***

Race Ethnicity
Non-Hispanic white (Ref)
Non-Hispanic black
Mexican-American
Other

1.08 (0.77, 1.53)
0.92 (0.65, 1.30)
1.14 (0.79, 1.65)

0.41 (0.32, 0.52)***
0.92 (0.75, 1.14)
0.80 (0.64, 1.01)

0.48 (0.34, 0.68)***
0.67 (0.49, 0.92)***
0.74 (0.53, 1.05)

Household Income
$0 to $19,999 (Ref)
$20,000 to $44,999
$45,000 to $74,999
$75,000 to $99,999
$100,000+

1.14 (0.81, 1.59)
0.98 (0.66, 1.44)
1.06 (0.65, 1.75)
1.11 (0.71, 1.72)

0.86 (0.70, 1.06)
0.90 (0.71, 1.14)
0.73 (0.53, 1.00)
0.61 (0.45, 0.80)***

1.03 (0.76, 1.40)
0.78 (0.54, 1.13)
0.73 (0.45, 1.18)
0.81 (0.53, 1.23)

Tobacco Exposure
Non-Exposed⁵ (Ref)
Environmental Exposure⁶
Tobacco User⁷

1.33 (0.75, 2.39)
1.05 (0.70, 1.57)

1.25 (0.97, 1.61)
1.62 (1.14, 2.31)***

0.93 (0.63, 1.37)
1.48 (0.91, 2.39)

Gender
Male (Ref)
Female
Age
6 to 8 years (Ref)
9 to 11 years
12 to 15 years
16 to 18 years

***ORs significant at the 0.05 level
Note: Dyslipidemias are defined as TC >=200 mg/dl, HDL-C < 40 mg/dl, and non-HDL-C >=145 mg/dl
th
th
¹Healthy Weight = BMI 5 – 84 percentile
th
²Underweight =BMI <5 percentile
th
th
³Overweight = BMI 85 to 94 percentile
th
⁴Obese = BMI >= 95 percentile
⁵Non-Tobacco Exposure = Cotinine level <1 ng/ml
⁶Environmental Tobacco Exposure = Cotinine level 1 to 10 ng/ml
⁷Tobacco User = Cotinine level > 10 ng/ml

CHAPTER V
DISCUSSION AND CONCLUSION
5.1 Study Purpose
BMI at the 85th percentile is the threshold to designate children and adolescents at
risk for dyslipidemia and screening is recommended by the Expert Panel. Although
research has demonstrated a positive relationship between obesity and dyslipidemia and
CVD, research specific to the relationship of overweight rather than obese youth and
dyslipidemias is lacking. The purpose of this study was to examine associations between
BMI at the 85th percentile or greater and dyslipidemias of total cholesterol, high-density
lipoprotein cholesterol and non-high-density lipoprotein cholesterol in children and
adolescents 6 through 18 years of age.
5.2 Descriptive Data
For the three lipid factors studied, mean value differences between males and
females are not significant. The present study found that the mean concentration of TC
among 6 to 18 year old youth is 158.7 mg/dl for males and 159.8 mg/dl for females. An
elevated TC is found in 7.7% of the study participants. This is lower than published
findings from other NHANES studies where approximately 10% of children ranging
from 6 to 18 years of age had elevated TC levels. Consistent with earlier studies children
in the younger age groups, 6 to 11 years of age have significantly higher mean values of
TC in comparison to those 12 to 18 years old. There is no significant difference found
among race/ethnicity groups for TC in this study. Whereas NHANES 1999-2006
analysis conducted by Ford, Li, Zhao, and Mokdad (2009) found blacks had higher
61

62
concentrations of TC in comparison to whites and Mexican-Americans. TC mean levels
are significantly lower in healthy weight children compared to overweight (-3.45 [95%
CI: -6.59, -0.31]) and obese children (-5.41 [95% CI: -8.26, -2.56]). There are no
significant differences in the mean TC values of participants based on household income
or tobacco exposure.
The most obvious finding in the descriptive analysis is the high prevalence of
HDL-C dyslipidemia. In the present study dyslipidemic HDL-C values are found in
27.4% of the participants. This prevalence is much higher than another NHANES study
from the 2001–2006 cycles, with published prevalence rates of approximately 19% for
HDL-C at or below 40 mg/dl (Johnson et al., 2009).
In all but one age comparison group, the mean values of HDL-C decrease with
age, most with significance. The exception is an increase in mean HDL-C value from the
6 to 8 year old group to the 9 to 11 year old children. Decreasing HDL-C values as
children age into adolescence may indicate that dyslipidemia is increasing in this study
group. This is consistent with reports by Li et al. (2010) who found a much higher
prevalence (57%) of HDL-C abnormality in adolescents, in comparison to 10 to 11 year
old boys (24%). In the present study, non-Hispanic blacks have significantly higher
levels of mean HDL-C in comparison with all other race/ethnic groups. This positive
finding is also reflected in this group’s dyslipidemia prevalence. Non-Hispanic blacks
have the lowest HDL-C dyslipidemia (18.8%) compared to all other race ethnic groups
(28.8 – 31.3%). This finding of racial difference is consistent with an earlier NHANES’
study by Johnson et al. (2009).
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In the present study, HDL-C demonstrates significant mean differences for income
and cotinine categories. Participants from households at the lowest income level have
mean HDL-C values approximately 2.17 mg/dl lower than the highest two income
categories. In regards to dyslipidemia development, it is reasonable to expect a
socioeconomic effect. Low-income groups are disadvantaged because they have less
access to healthful foods, fewer physical activity options and generally experience stress
related to their life condition, which can contribute to obesity development. Study results
for tobacco exposure are more dramatic, the changes in mean values of HDL-C decrease
by a mean value of 5.11 md/dl for a tobacco user versus a non-tobacco user. These
findings concur with known risk factors for low HDL-C, which include smoking, lack of
physical activity, excess body weight, and a diet high in refined carbohydrates (Harvard
University, 2012).
Of all the variables analyzed for mean differences the most profound difference is
found in the BMI percentile for HDL-C. Mean HDL-C values consistently decrease,
inversely to BMI percentile category increases, all with significance except for the
underweight and healthy weight group. Although not significant, the mean HDL-C value
for the healthy weight group is still lower than the underweight group.
Non-HDL-C mean values are 106.1 for males and 107.1 for females. In this study
population 9.1% have abnormal non-HDL-C levels. Significant results for mean values
of this lipid factor involve age groups, race ethnicity and BMI percentile findings. In
regards to age groups, 12 to 15 year old children have significantly lower mean values
than all other age groups. Although specific research on non-HDL-C is lacking, this
seems to be consistent with dyslipidemia studies in general that have found decreases in
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cholesterol levels during puberty. In this study sample, non-Hispanic blacks have
considerably lower non-HDL-C values than all other groups studied ranging from 4.3 to
5.3 mg/dl less. The results for BMI percentile categories and resulting difference among
non-HDL-C mean values is significant for all combinations, except the healthy weight
and underweight comparison. In all cases, higher BMI percentile categories have higher
mean non-HDL-C values in comparison to lower BMI percentile groups.
5.3 Test Agreement
Predictiveness of BMI percentile overweight category (85th through 94th
percentile) at detecting dyslipidemia is evaluated by constructing two by two tables and
calculating sensitivity, specificity, PPV and NPV for each of the three lipid factors. A
true positive test is defined as an overweight, but not obese child, who also has a positive
lipid abnormality. A false positive test is defined as an overweight, but not obese child
with a negative test for lipid abnormality. A true negative test is defined as a healthy
weight (5th through 84th percentile BMI) child, who also has a negative test for lipid
abnormality. A false negative test is defined as a healthy weight child with a positive
lipid abnormality.
Overall sensitivity for all three lipid factors is poor ranging from a low of 30.4%
for TC to 36.3% for non-HDL-C. Specificity in comparison is in a much more
acceptable range of 78.4 to 80.7%. The overall PPVs are very low at 9.1% for TC and
10.7% for HDL-C. The PPV for HDL-C demonstrates the most discrimination, but is
low at 31.0%. Test agreement statistics stratified by age categories produces interesting
results. For both TC and non-HDL-C, the 9 to 11 year old group has the highest
sensitivity and PPVs. Sensitivity for HDL-C increases commensurate with increasing
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age categories, but the 12 to 15 year old group has the highest sensitivity (38.8%),
whereas the 16 to 18 year olds has the highest PPV (37.8%). The NPVs are high ranging
from 82.1 to 94.7% and consistent with earlier research by Lee et al.
Test agreement analyses from previous research is not entirely consistent with the
present study, however parameters used also differ which make them difficult to
compare. In the Project HeartBeat study, results included similar sensitivity and
specificity levels, but higher PPV values for TC (26%) and HDL-C (24%) (Eissa, Wen,
Mihalopoulos, Grunbaum, & Lararthe, 2009). Lee et al., (2009) studied NHANES data
from earlier years and reported much higher sensitivities, 51% for TC and 64% for HDLC and different PPVs 14% for TC and 11% for HDL-C.
The PPV for TC (9.1%) in the present study is lower than results (14%) from Lee
and colleagues (2009). The PPV for HDL-C (31.0%) is much higher than 11% found in
the earlier study by Lee et al. This may be a function of disease prevalence, as this study
has a higher prevalence of HDL-C positive dyslipidemia than earlier research. Positive
predictive values increase in accuracy with increasing disease prevalence. In the present
study, prevalence of TC is 7.7% and for HDL-C 27.4%. In contrast, Lee et al. reported
higher TC prevalence (males 8.2%, females 10.2%) and much lower HDL-C prevalence
(males 7.9%, females 5.4%). The study by Lee et al. was on subjects from NHANES
cycle years 1999-2004. What is alarming here are the indications that HDL-C
dyslipidemia prevalence may be substantially higher in US youth today compared to
levels from only one decade ago.
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5.4 Logistic Regression
The variables of BMI percentile and age dominate the associations found in both
the simple and multivariate models. The most profound results are in the BMI percentile
categories. For all three lipid factors, as children increase from overweight to obese
categories their ORs for dyslipidemia increase. These findings remain significant after
controlling for gender, age, race ethnicity, income and tobacco exposure. The risk for
dyslipidemias among obese children is about two times that of overweight children (TC
1.5 to 2.1; HDL-C 2.0 to 5.0; non-HDL-C 2.1 to 4.2). These findings are consistent with
studies that have shown increasing relative risk for dyslipidemias as BMI weight status
categories increased (Freedman, Dietz, Srinivasan, Berenson, 1999; Holl et al., 2011).
Age related risk differences were found in this study. The protective effect of the
pubertal years is especially noted for TC with a significant OR = 0.7 for children 12 to 15
years of age. This value remains unchanged in the multiple logistic regression model
after controlling for all other independent covariables. Significant findings in the age
categories for HDL-C and non-HDL-C also remain essentially unchanged in the multiple
logistic regression model compared to the univariate analyses. HDL-C odds ratios are
higher as age categories increase (OR = 1.3 to 2.0). For non-HDL-C, the OR for the 12
to 15 year old group is less than the other age categories, but this finding is not
significant. These study findings are consistent with lipid value changes in relation to
pubertal maturation also found by Bogalusa researchers and Kwiterovich et al., 1977
(Berenson, Srinivasan, Cresanta, Foster, & Webber, 1981).
Although a number of large studies exist that have found increased TC values
among black children in comparison to white children, this study did not find significant
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differences among race ethnic groups for TC dyslipidemia (Freedman, Lee, Byers,
Kuester, & Sell, 1992; Frerichs, Srinivasan, Webber, & Berenson, 1976; Webber et al.,
1991). Study results for TC are also inconsistent with a study by Resnicow and
colleagues who found significantly higher TC values for both black and Hispanic
children in comparison to white children (1989). This study’s logistic regression analysis
revealed significant findings in the race ethnicity categories for HDL-C and non-HDL-C
dyslipidemias. Non-Hispanic black subjects demonstrate a protective effect against
HDL-C (OR = 0.4) and non-HDL-C (OR = 0.5) dyslipidemia in simple and multivariate
logistic regression. After controlling for gender, age, BMI percentile, income and tobacco
exposure, Mexican-Americans also have a significant decreased risk for non-HDL-C
dyslipidemia (OR = 0.7).
Prior research and statistics exist which agree with this study’s findings in regards
to the protective effect of non-Hispanic black race and HDL-C dyslipidemia. NGHS
researchers found decreased risk for African-American girls to exhibit unhealthful HDLC and 2012 Heart Disease and Stroke Statistics report much higher HDL-C mean values
in non-Hispanic blacks compared to non-Hispanic whites and Mexican American boys
and girls (Roger et al., 2012; Thompson et al., 2007). However there are some
inconsistencies with this study’s findings and prior research. Bogalusa investigators
found that non-HDL-C values were similar in black and white children, and Tortolero
and colleagues found Mexican American boys had slightly lower HDL-C levels than nonHispanic white boys (Srinivasan, Myers, & Berenson, 2002; Tortolero et al., 1997).
In adults, socioeconomic status strongly predicts CVD risk factors. A study of
NHANES subjects from 1999-2008 found 6 to 17 year olds from low-income families
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have higher prevalence of obesity, sedentary behavior and tobacco exposure, all of which
are risk factors for abnormal low HDL-C levels (Ali et al., 2011). In the present study,
household income is included to account for socioeconomic influence on the outcome
variables. HDL-C is the only lipid factor with a significant finding. Youth from homes
with the highest income, greater than $100,000 a year, have 40% less risk for HDL-C
dyslipidemia than children from the lowest income households. This significant finding
remains unchanged after controlling for BMI percentile, gender, age, race ethnicity and
tobacco exposure.
In the present study, tobacco use risk demonstrates the most change between
simple and multiple logistic regression analyses. Tobacco users in simple logistic
regression are at greater risk for HDL-C (OR = 2.1) and non-HDL-C (OR = 1.9)
dyslipidemia. This is consistent with previous studies that have found unfavorable
changes in plasma lipids, including HDL-C, amongst youth who smoke tobacco (Clarke
et al., 1986; Craig, Palomaki, Johnson, & Haddow, 1990; Glueck, Heiss, Morrison,
Khoury, & Moore, 1981). In the multivariate logistic regression, tobacco users risk for
HDL-C abnormality reduces to OR = 1.6, but remains significant. For non-HDL-C
dyslipidemia, the risk from tobacco use is no longer significant (OR = 1.4 [95% CI: 0.9,
2.4]) after controlling for all other covariables, BMI percentile, age, gender, race
ethnicity, and income.
5.5 Public Health Implications
Atherosclerotic CVD is the leading cause of death in the US and many risk factors
that contribute to development of atherosclerosis begin in childhood. The basis for
screening children at risk for dyslipidemia is a function of primary prevention with the
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goal to identify children at increased risk and to prevent CVD development by effectively
managing risk factors. Pediatric guidelines include targeted screening of children with
BMIs at or greater than the 85th percentile, but studies are lacking on associations of the
overweight BMI category children and dyslipidemia.
Findings from this study have contributed to the body of knowledge concerning
the relationship of youth BMI percentiles and dyslipidemias of TC, HDL-C and nonHDL-C. The results of this study provide additional statistics on the current prevalence
of lipid levels in US youth in the context of gender, race, age, income, tobacco exposure
and BMI percentiles. Further information is presented on test agreement and association
of BMI at the 85th percentile and dyslipidemias of TC, HDL-C and non-HDL-C. This
study has contributed to the body of knowledge of BMI percentiles and relationships with
abnormal levels of TC, HDL-C and non-HDL-C by examining a large sample of US
youth. Overall, results from this study can be used as a reference for additional studies
and for planning intervention programs that aim to reduce the burden of CVD.
5.6 Strengths and Limitations
The major strengths of this study are related to the source of the data NHANES.
NHANES surveys are conducted in a manner that uphold the highest research standards
and result in a high quality, comprehensive data bank of health information from a
national representative sample of the US population. Another major strength of this
study is the relatively large sample size, which lends itself to greater statistical
significance and representation from three distinct race/ethnicity groups. Also due to the
comprehensive nature of NHANES, it was possible to include considerable details related
to the participants and to include non-HDL-C in the study.
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Limitations of this study are that not all race/ethnic groups could be represented.
In particular, NHANES does not have a separate category for Asians and it would have
been informative to include this group in the analysis. In some regards, it was difficult to
include confounders due to nuances of NHANES. Thus the study does not include
variables related to hypertension and diabetes, which are known high risk factors for
atherosclerosis development. There were limitations in the selection of lipid factors
selected for the study. Triglycerides and low density lipoprotein-cholesterol are not
included because this would have decreased the sample size and limited the age of the
study sample to those over 12 years. NHANES is a cross sectional survey and there was
only one laboratory value for each lipid factor. Individual lipid levels can vary and
evaluation should not be based on a single laboratory test. Thus, a limitation is that only
one value per lipid factor was available for this study.
5.7 Recommendations
Obesity is clearly established as a CVD risk factor, however studies on overweight
youth and dyslipidemia are lacking. This study has contributed to the body of knowledge
of youth risk for dyslipidemias according to BMI weight status categories. Results of this
study support continued screening of children and adolescents in the overweight
category, as both overweight and obese youth were found to be at increased risk for
dyslipidemias. Although targeted screening of overweight children was not supported by
results of the test agreement analysis, these analyses may have been problematic due to
the multifactorial basis for dyslipidemia and low dyslipidemia prevalence found in the
sample. Further research on associations of pediatric overweight, obesity and
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dyslipidemia, and specifically studies on the effectiveness of BMI at the 85th percentile as
a predictor of dyslipidemias in youth are warranted.
In regards to race and ethnicity, most studies have been conducted on non-Hispanic
whites and non-Hispanic blacks. Additional research on a broader range of race/ethnic
groups is needed, especially in US Hispanic and Asian populations. Further studies are
needed to assess the relationship of tobacco use and dyslipidemias. Tobacco use is a
known risk factor for dyslipidemias, however in this study the multivariate regression
analysis revealed significant findings only for HDL-C.
It is important to continue surveillance of distinct dyslipidemia prevalence among
our youth. Full lipid profiles are more revealing. Results of the present study found
differences in TC, HDL-C and non-HDL-C dyslipidemia prevalence, as well as
differences in dyslipidemias according to age and race ethnicity groups. The prevalence
of HDL-C was alarming, as it was much higher in this study cohort than had been
reported in earlier research. These findings validate the importance of monitoring lipid
factors and dyslipidemia prevalence in our youth.
The obesity epidemic is of utmost concern and the evidence base is strong that
obesity is a major risk factor for CVD, as well as other risk factors for CVD such as
dyslipidemias and diabetes. Additional studies on the effects of physical inactivity and
diet in regards to dyslipidemias could add valuable information for both risk conditions.
Further studies may reveal a genetic component related to ethnic origin and responses to
diet or physical activity levels. For example, some groups may have less tolerance for fat
intake or respond more positively to physical activity.
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Studies that analyze the effects of screening youth and detecting dyslipidemias,
which may lead to identifying additional family members with dyslipidemias, could
reveal a secondary benefit from screening youth, in that we could ameliorate the health
consequences of CVD in two generations simultaneously. This could also lead to studies
that examine the relationship of a mother’s or father’s dyslipidemia status and those of
their children. Prospective studies on children through adulthood, which examine their
CVD risk status, how risk status changes over time, if knowledge of risks effects
behavior, the effects of intervention and incidence of CVD, would ultimately offer the
most credible information on CVD screening in youth and planning CVD prevention
programs.
5.8 Conclusion
This study has provided further evidence that not only obese, but overweight
children are at greater risk for dyslipidemias of TC, HDL-cholesterol and non-HDLcholesterol. Findings show the importance of analyzing individual lipid factors,
especially HDL-C in contrast to only obtaining a TC value, as the components offer a
much better picture of the individual’s lipid status and each lipid factor seems to be
affected by risk factors differently. As in earlier reported research, BMI at the 85th
percentile did not provide good discrimination in detecting children and adolescents with
dyslipidemia. Thus despite this study’s findings that overweight children are at increased
risk for dyslipidemias, overweight status and perhaps even obesity, may not be strong
enough risk factors individually, to translate into a good screening indice for youth
dyslipidemia. Use of BMI at the 85th percentile as a threshold for dyslipidemia screening
in youth warrants further consideration. Considering age-related prevalence and the lack
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of predictiveness of major screening criteria, such as family history and BMI at the 85th
percentile, the recent change in recommendations by the Expert Panel to include
universal screening of 9 to 11 year old children is affirmed and may obviate the need to
target screen overweight children for dyslipidemia.
Atherosclerotic cardiovascular disease is the leading cause of death in the US and
CVD is a chronic condition that begins in youth. Public health primary prevention goals
aim to reduce the burden of CVD by reducing risk factors early in life. The high
prevalence of overweight and obese US youth is a public health concern for the
development of chronic diseases, including CVD. The results of this study, and other
research, have demonstrated that overweight and obese youth are at increased risk for
dyslipidemias. It is important to continue public health efforts to reduce obesity
prevalence, as well as other risk factors, which lead to adult CVD. Public health
surveillance and study of lipid levels in youth and risk behaviors that can lead to
dyslipidemias, atherosclerosclerosis and CVD is vital, in the effort to better understand
this disease process, promote prevention programs and ultimately to reduce the burden of
cardiovascular disease.
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